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SENATOR WATSON: Good afternoon and I'd like 
to welcome all of you to this special hearing of the 
senate Health and Human Service Committee. We have 
6 convened this afternoon to explore one question, "Are 
7 needle exchange programs effective in combating AIDS?". 
8 Needle exchange programs on a one to one basis, 
9 needles on the street for uninfected needles, is something 
10 that we want to hear more about. In other words, dirty 
11 needles are exchanged for clean ones without adding to the 
12 total number of needles on the streets. 
13 These programs have become a subject of intense 
14 debate in the field of AIDS prevention and substance abuse 
15 treatment. Proponents claim needle exchange programs may 
16 decrease the spread of HIV infection among HIV users. 
17 Opponents argue that such programs condone and promote 
18 illegal drug use. We will have the opportunity to explore 
19 this controversy over the next few hours as we hear from 
20 expert witnesses on the beneficial and harmful effects of 
21 needle exchange programs in efforts to curb HIV or IV drug 
22 use and the spread of AIDS. 
23 Early in July of this year, the California AIDS 
24 Leadership Committee issued its strategic plan for the 
25 California continuing response to HIV disease. The 
committee identified the problem of the rise in HIV 
infection among IV drug users due to the sharing of drug 
3 i ection paraphernalia among users. The committee 
4 recommends to this problem, -- The committee 
5 recommendation to this problem is the enactment of 
6 legislation to establish and fund pilot paraphernalia 
7 exchange projects in California. The committee, however, 
8 does caution and emphasize that such programs are not an 
9 end in themselves. The report states that paraphernalia 
10 exchange programs should be viewed as merely one component 
11 of a comprehensive program designed to discourage drug 
12 abuse as well as prevent further spread of HIV infection 
13 among IV drug users, their sexual partners, and their 
14 offspring. There is no easy solution to address the rise 
1 of HIV Infection among IV drug users. It would be short-
16 sighted for the legislature to set the policy direction 
17 r health officials in this state on needle exchange 
18 pr rams without public input and exploring and 
19 understanding the controversy surrounding these programs. 
20 So, I want to thank all of you for coming and 
I'd like now to begin the dialogue between the proponents 
and the opponents of the needle exchange program. 
I'd like to introduce now our first speaker, 
George Clark. Mr. Clark is the Coordinator of Prevention 








ad hoc basis in the city of San Francisco. I believe, Mr. 
Clark, that you have some slides that you want to show? 
MR. CLARK: Yes. 
SENATOR WATSON: Okay, that may be seen over 
our heads or should we --
MR. CLARK: I think you can see them. You'll 
7 turn around when the slides come on. They'll dim the 
8 lights when it happens,or they'll dim them now,and they'll 
9 be ready. 
10 SENATOR WATS0N: Okay. 
11 STATEMENT BY GEORGE CLARK 
12 MR. CLARK: Hi, I'm George Clark. I'm one of 
13 the people who work with Prevention Point, a street-based 












here today to present information on the issue of needle 
exchange as an HIV intervention and, in particular, about 
Prevention Point, San Francisco's street based needle 
exchange. However, before I do that I would like to make 
two requests of you. 
The price of needle exchange as an HIV 
prevention/intervention is a complex issue. It demands 
your full attention to weigh and analyze the pros and 
cons. However, I believe it is important that we don't 
lose sight that it is a completely human problem. The 
decisions that you make about this issue will affect the 
1 lives of hundreds of individuals. 
4 
It's important that we 
2 esent these individuals into the process. This can only 
3 remain an academic, moralistic and intellectual debate in 
4 the absence of the injection drug users. The effects of 
5 our needle exchange can be heard in the words of Nancy, a 
6 32-year-old heroin user who has been using for 10 years. 
7 She said this in a recent interview: "You know, a lot of 
8 people here are using clean needles now, whereas before 
9 they weren't. Everybody was sharing needles before. You 




know, if I didn't have them here they'd use mine: I 
know it. But now it's not like that anymore. " so, i f you 
listen to the information you get today from the different 
presenters, present Nancy in your mind and the effect of 
having access to sterile injection equipment does to 
her. 
I also want to request you to be prepared to do 
some difficult evaluation. Some of the findings in needle 
xchange research are counter-intuitive; they only make 
after deeper analysis. So don't be prone to jump to 
decisions. People are quick to conclude that needle 
hange promotes drug use. However, in the Netherlands 
re needle exchange has been implemented since 1980 for 
ontinues as an intervention during the Hepatitis B 
ic, and now for HIV, there have been exchanges of 
5 
hundreds of thousands of syringes, and there is no evidence 
2 that it promotes drug use. The number of drug users in 
3 Amsterdam remains stable from the period of 1983 through 
4 1988. The average age of an injection drug user has risen 
5 from 26.8 in 1983 to 30.8 in 1988. That happened while 
6 the percentage of young drug users, those are drug users 
7 under the age of 25, diminished from 14.4 percent of the 
8 injection drug-using community to 3.4 percent in '88. 
9 This contradicts the argument that access to sterile 
10 injection equipment will promote needle use among users. 
11 The fact is that 38 percent of the people who participated 
12 in Amsterdam's needle exchange have reduced their drug 
13 use. 
14 During the period of 1983 to 1987, the number of 
15 drug users seeking drug-free treatment doubled. This 
16 indicates that it may even be that needle exchange is 
17 assisting people to choose out of the drug life. 
18 What is true wherever needle exchange has been 
19 implemented as an HIV intervention is that participants 
20 have reported safer needle use. Data gathered by John 
2 1 Waters of the Urban Health Study in early 1989, only 18 
22 weeks after the beginning of our intervention, indicated 
23 that the more often the injection drug user used our 
24 program, the more likely they were not to share. 
25 Prevention Point is a coalition of community-
based AIDS prevention organizations and people which 
ncludes the Third world Advisory Task Force and the 
6 
Latino Coalition on AIDS. Its members include health care 
4 workers, people in recovery, social scientists, HIV-
infected people, teachers, lawyers, painters and community 
6 organizers. Prevention Point is supported entirely by 
7 private donations. Our objective is to intervene in the 
8 spread of HIV among high risk communities that are at risk 
9 through contaminated needles. Used needles are accepted 
10 into a bio-hazardous waste container, and new sterile 
ins lin syringes are dispensed on a one-for-one exchange 
bas s. 
13 The syringes in the past were marked and 
14 monitored to establish return rates, and several 
15 ndependent experienced AIDS research organizations are 
6 c nducting evaluations and studying Prevention Point. 
Prevention Point sees needle exchange as but one 
part o a com ehensive HIV prevention program. Bleach, 
oms, cultural and linguistic-appropriate education, 
t ach, risk reduction counseling, greater access to 
21 r mary health care, perinatal care and a wide range of 
dr treatment are all necessary. we began because we 
knew that there was shortages of injection equipment that 
were promoting sharing. In the research and the 
ter a ture, the major reason for sharing syringes given by 
7 
injection drug users are shortages of equipment and having 
2 laws against possession of sterile injection equipment. 
3 A number of us who are working on a research 
4 project and as part of an interview that we administered 
5 to injection drug users, asked for their ideas about how 
6 to stop the spread of AIDS in their communities. Again 
7 and again people spoke of being forced to share by 
8 shortages of syringes and suggested that we make sterile 
9 injection equipment more available. 
10 Let's see, does this work? 
11 SENATOR WATSON: While you are trying to get 
12 that to work, what do you do with the needles that you 
13 collect? 
14 MR. CLARK: we currently take them to the 
15 Department of Public Health who disposes them as bio-









SENATOR WATSON: Are they taking them? 
MR. CLARK: Yes. 
SENATOR WATSON: Could they incinerate them 
or melt down the metal that's in the needle? 
MR. CLARK: I don't know exactly -- Doctor 
Werdegar will present later -- I don't know exactly how 
that kind of bio-hazardous waste gets dealt with. 
SENATOR UATSON: Because they are ending up 
25 on beaches and in other places and I'm wondering why they 
don't try to melt the metal. 
2 MR. CLARK: I think when they end up on beaches 
3 they're being disposed of illegally and not properly as 
4 bio-hazardous waste. So I think, especially on the East 
5 coast, that was the case of people that were just taking 
6 them and putting them into garbage when it should have 
7 been bio-hazardous waste. 
8 SENATOR WATSON: Right, okay. 
9 MR. CLARK: On November 2nd we began our 
10 intervention. On that day we exchanged 13 needles. On 
11 November 16th, 1989, so that's a year later, in a single 
2 two hour period, we exchanged over 2100 syringes with more 
8 
than 360 individuals. That is in three locations in the 
14 streets of San Francisco. In total, since we started in 
15 1 88, we have exchanged 31,448 syringes and have made 
7,352 client contacts. These total client contacts, some 
em are duplicated, we can't tell how many are--
Initially, we began with two teams. Here are 
f the syringes we first got. This, in fact is what 
all -- sort of, you know how people always hang up the 
t dollar hey got? That was one of the syringes we 
got, so you can see the condition of the syringe. So 
t se are initially the syringes we got the first time. 





MR. CLARK: We don't, but in cooperation with 
the University of California, we're attempting to better 
understand the technology. The people in Australia -- it 
is possible to do PCR's on syringes, to test for HIV 
5 prevalence. We're also interested to do it as a 
6 verification of self-report measures, since most of the 
7 evidence is self-report. 
8 This is the take from that night where we did 
g 2100 syringes so you can see. 
10 SENATOR WATSON: My goodness. You did this 
11 in one night in an exchange program? 
12 MR. CLARK: 2100 in one night in two hours at 
9 
13 three different locations. The total client contacts that 
14 night were 360 individuals. We'll exchange one-to-one up 
15 until ten. 
16 Go to the next slide. This is our Prevention 
17 Point needle exchange program work by month so you can see 
18 how quickly --well, it looks like a normal curve. It 
19 ends the month of October, the data was only in up until 
20 October 18th; in fact, in October we exchanged slightly 
21 over 6,400 syringes, so it looks like the beginning of a 
22 normal curve that keeps going on. 
23 The next slide please. 
24 SENATOR WATSON: Are they using more because 
25 they can get clean needles? 
MR. CLARK: 
10 
I think they use a needle less times 
2 so in a way they're using more needles physically. 
3 There's no evidence in the literature that people shoot up 
4 more. We only have preliminary data. John Waters of USC 
5 staff and the Urban Health Study has a grant through AMFOR, 
6 and it will in the beginning of December gather more data 
7 about, self-report data --
8 SENATOR WATSON: Now is this mostly heroin 
9 used or is this a mixture? 
10 MR. CLARK: Our location in-- it's interesting. 
The two different types of one team is a roving team 
12 hat goes place to place. In fact, if you go to the next 
13 slide we'll look at the street scene. Again, another 
li , this is more needles. We have lots of pictures of 
15 ne les. 
16 
17 
Here's the street location. That's in the 
erloin on Taylor and Ellis. Initially, we did this 
two ways. We did a stationary team that stays in one 
lace and people come to, and a roving team that moves 
t r ugh civic center, down UN plaza and then down to 6th 
et. That was done because we wanted to see how it 
uld work. 
SENATOR WATSON: Do you get hassled? Are you 
ssled by law enforcement? 




occasions. one was when we were having what we called the 
"media circus" which was when the media wanted to come on 
site. we said all right, we'll do it one night, because 
4 we weren't able to contain them,and they were showing up 
5 on the site anyway. So we had this and that night one 
6 of the people got a citation which was very much like a 
7 ticket and when they went to court that was dropped. The ' 
8 next week someone called, and we got two more citations, 
9 but other than that we haven't been hassled. 
10 If you could go to the next couple of slides. 
11 These are just street scenes. 
12 SENATOR WATSON: Tell us what we're seeing 
13 here. 
14 MR. CLARK: This is the needle exchange. 
15 SE~JATOR \'lATSON: Is that your vehicle? 
16 MR. CLARK: Actually, that is one of our cars. 
17 But at the feet of the person -- the woman on the right 
18 with the hat is dropping a syringe into a bio-hazardous 







jacket is actually giving her alcohol wipes, I believe. 
There's a guy that's obscured behind them, he's taking 
data and the woman over to the right is basically doing 
what we call crowd control. 
You can go to the next picture. 
SENATOR WATSON: So let me just ask you about 
it. You have three people out there? 
2 MR. CLARK: This night there were probably --
3 Usually on a team there are five or six. At this point 
4 two of the team members have gone out into the street to 
5 tell people in the street that the needle exchange is 
12 
6 ha ning. We are dealing with a group of people who are 
famous for not showing up on time. That's when you think 
8 about 2100 syringes, 360 people in a two hour period, it's 
9 pretty incredible that these people, who are famous for 
10 not getting anywhere within two hours, show up. 
11 SENATOR WATSON: Now, you don't touch the 
needle yourself? They take the needle and put it into 
MR. CLARK: No, we ask them to show it, rtnd as 
drop them in, we count. So, in fact, you can't really 
t these are not great photos-- but there's a 
with a bio-hazardous waste container. So, we don't 
r come close to the syringes. 
There's another couple of slides of this street 
He e is the roving team on 6th Street. The blo-
rdous waste container in this situation 1s over here 
1 the baby buggy. If you'll show the next slide. 
SENATOR WATSON: Are you camouflaging it, 
sing it? 
MR. CLARK: Well, when we first did this our 




















interested in gaining anybody's attention so we, in fact, 
figured this was something the street people would know 
and it wouldn't be that unusual. That's a 1943 
perambulator, a dolly perambulator. 
SENATOR WATSON: That's unusual, for sure. 
MR. CLARK: Yes. So, if you show again, you can 
see-- and if you'll show one more slide you'll get to see 
-- the code word on the street is "we want to feed your 
baby". 
SENATOR WATSON: Oh, I see. 
MR. CLARK: So people say, "Oh, if you want to 
feed the baby it's right there, and you can deposit your 
needles in there and we'll give you" Basically, the 
model is street-based,and it's based on the existing 
Tacoma, washington model. 
What we feel is that the model should be street-
based and that the program should supply sterile injection 
equipment, cotton, alcohol wipes, AIDS prevention 
information, bleach and condoms,and it should be available 
20 in an non-judgmental, user-friendly environment. We 
21 believe that there should be no requirement for 
22 participation other than the possession of a syringe and 
23 the willingness to exchange. 
24 SENATOR WATSON: Now, you supply all of these 
25 supplies? 
14 
MR. CLARK: Yes. 
SENATOR WATSON: And that's through the 
3 donations? 
4 MR. CLARK: Yes. Initially, this was not -- in 
5 fact, initially up until May 24th when I was writing a 
6 poster that we presented in Montreal about the exchange, 
we had exchanged 4,500 syringes. It looks like in the 
8 month of November alone we're going to break 8,500. 
g SEHATOR WATSON: So, if you have those, you 
10 have to give one in exchange. 
11 su lies in that bulk? 
How do you buy your 
12 MR. CLARK: There are only eleven states in the 
13 District of Colombia that demand a prescription to buy 
14 syringes and, of course, I would never do such a thing, 
E, but -- l did at one point, l was an employee at the 
6 University of California, San Francisco as a buyer of 
cal supplies, so I kind of know how to do that sort of 
ing, but I would never do anything like that. 
19 SENATOR WATSON: Of course not. 
MR. CLARK: We basically reach out to the 
lDJ t1on drug user as a valuable and respected 
nd vidual, which is different than most people reach out 
nJection drug users. They confuse the war on drugs 
w1th the war on drug users, often, and regardless of what 
evaluate their choices -- Like, I myself as a person in 
15 
recovery do not think using is the best thing, but I also 
2 know that recovery is a process of attraction and not 
3 promotion. one can't badger someone else into recovery; 
4 they have to be ready to move towards recovery. 
5 We view addiction and substance abuse as a 
6 social, economic and public health problem and believe its 
7 solutions are to be found in a social context. our major 
8 concern,and the most difficult thing for injection drug 
9 users or for all drug users for that matter in this 
10 culture, is that there is no access to treatment. We 
11 always talk about just say "no", but just say no for a 














early intervention among adolescents,and I think it's 
questionable at that. But we believe there should be 
treatment on demand with no waiting list. We do referrals 
to treatment,but it's incredibly hard to tell somebody, 
"Well, you can go here six or seven days, 7:00 in the 
morning, show up dope sick and maybe you'll get in on the 
eighth day." 
Nancy, the woman who I quoted in the beginning, 
talked about, I don't have her quote with me, but she 
talks about her heroin habit as she's either well or she's 
sick. In her frame work it is not about being high. It's 
either she's sick, she needs the drug; or she's well, 
she's gotten her fii. So, telling someone to wait seven 
16 
d s and show up sick I mean we tell them to show up 
2 si because you have to demonstrate need to get into 
3 treatment just doesn't work. 
4 SENATOR WATSON: Do you do anything with 
5 evention when you talk with them? 
6 MR. CLARK: I talk about, in the context -- I 
7 view what I do in the context of 12 steps as in 
8 12 step program which is "reach out to the addict that 
9 still suffers" and I talk about what my process of 
0 r ery was about and talk about how I managed to stay 
11 ars clean and sober. People like to hear that; 
from me often because I don't look like an ex-
i ection drug user. 
SENATOR WATSON: How did you come to the 
ilitation process? 
MR. CLARK: I was -- in a lot of ways it was just 
luck. I didn't think I had a problem. I was pretty 
in denial. 
NA meeti 
I'm sort of an interested person. I went 
just to hear and sort of experience what 
s like because somebody I knew was in recovery,so I 
I'll go check this out. This isn't about me, but I'll 
it out. I heard speaking at that meeting 
who was about 20 years older than I am, had my 
story but was speaking from 20 years down the road, 














there had been a hit and run,but not knowing whether their 
vehicle was the one because there had been blood on their 
bumper. 
I like listened to it and said, "Oh my God, this 
could be me", and I looked at my family history in which 
there were a number of -- an Aunt of mine died in the 
Bowery, a single-room occupancy hotel, and I said I don't 
want to know if the end of cocaine and alcohol for me is 
going to be there, or is it going to be like my father who 
is sort of a nice,controlled drinker. He sort of has his 
problems, gets better. I just didn't 
SENATOR WATSOH: Addictive personality? 
MR. CLARK: Yeah, I didn't want to find out. 












incredibly lucky because I didn't reach a bottom like a 
lot of people have to. I just sort of went, and I looked 
and I was 32 at the time, and I said I'm not going to do 
this. I don• t want to find out. 
SENATOR WATSON: Uhat were you ingesting? 
MR. CLARK: I mostly did cocaine and alcohol. 
Not often injecting cocaine but occasionally because as 
the quantity of cocaine I was using was expensive,and it 
was a more efficient means of getting high. 
SENATOR WATSON: Do you do them both at the 
same time? 
18 
MR. CLARK: Mostly, I would do them both at the 
2 same time sort of to take the edge off. The alcohol would 
3 take the edge off the cocaine. 
4 SENATOR WATSON: Then more cocaine to put it 
5 back on? 
6 MR. CLARK: Yeah, it's incredibly-- It's sort 
7 of your professional's drug of choice. It's a lot of those 
8 people that you don•t know have the problem. That's what 
9 they're doing. 
10 SENATOR WATSON: I do know. 
11 MR. CLARK: Right, but you know sometimes you 
12 don't know. 
13 SENATOR WATSON: You can tell in behavior. 
14 Yo don't know but you can certainly see --
15 MR. CLARK: I always liked to think that nobody 
18 cou tell. You know, the denial lasts even after. 
7 So, basically what I think, you know, 
18 iction has not worked. The funds available for the 
19 an/Bush -- and the article that Nadleman had in 
ence is incredibly interesting. In 1987 alone, the 
21 this country spent 10 billion dollars on 
22 diction. That's a hell of a lot of treatment. And 
23 
24 
that period, the price of a kilo of cocaine dropped 
80 percent. During that period also, the quality of 








percent pure. So, the drugs are getting better, getting 
cheaper, and yet we're spending 10 billion dollars on 
interdiction, and there's no money for treatment or 
recovery. 
So, we know that needle exchange and 
distribution programs have been operating in New York 
City; Tacoma, Washington; Boulder, Colorado; San 
Francisco, California; vancouver, British Columbia; 
9 Montreal, Quebec, Toronoto and Ontario. Programs abroad 
10 include England, Scotland, the Netherlands, Australia, 
19 
11 Sweden, Poland and Italy. In places where needle exchange 
12 has been implemented, participants have reported safer 
13 needle use,and there has been no evidence of increased 
14 drug use. 
15 Syringe exchange schemes attract participants 
16 that are not reached by other public health interventions. 
17 These participants may indeed be persuaded to opt for 
18 treatment, although I feel needle exchange should be 
19 treatment-based, I mean treatment-linked but not treatment-
20 based. It should not be mandatory. In New York it is 
21 mandatory that you be on a waiting list to go to 
22 treatment. In New York it is methadone maintenance where 
23 people are being sent which some people want. I don't 
24 know how valuable a modality of treatment that is 
25 substituting one opiate for another. so, we don't believe 
2 
it should be treatment-based,but we think it should 
treatment-linked. That through needle exchange one 
20 
3 be able to have the option to get into any number 
4 modalities,such as some interesting and new modalities 
5 being developed, such as by Bayview Hunter's 
6 San Francisco which is treatment that includes 
7 symptomatic detox, or a Haight Ashbury Free 
8 which uses clonodine patches. So there's other 










Basically, internationally needle syringe 
-- I was in Montreal in June. There was like 
exchanges in non-HIV intervention. It's not 
the data's in. In places as diverse as Holland 
England,the data's in,and it's an accepted 
rvention. We're here sort of waiting and arguing and 
izing about this issue, and I know there are people 
e getting infected today. I used to think I did 
for me. I'm an HIV pre-test and post-test counselor 
t my work, and it's really about me not having to 
another person that they're HIV positive. The 
I ever gave a result to was to a black woman 
r mid-30's with two children. She had been clean for 
t months, and I had to tell her that she was HIV-
itive,and I had to see her cry when she was saying, "Am 
I going to be able to survive to see my kids live?". I 
2 don't want to have to do that anymore. So it used to be 
21 
3 about somebody else, but I know it's about how I'll keep my 
4 balance throughout this epidemic. I'll know that I've 
5 done everything that I could, and I want to challenge you 
6 to do everything you can because there's no time to argue 
7 and moralize about it. 
8 SENATOR WATSON: Are you through with the 
9 slides? 
10 MR. CLARK: Actually there's a couple of more if 
11 you want to go through them quickly. There's a slide at 
12 the end that will end. 
13 
14 
SENATOR WATSON: Okay, we'll let you. 
MR. CLARK: This is a team in a mission and I 
15 think there's-- These are the syringes and the data, and I 
16 said there's a box of alcohol wipes but there isn't, and 
17 that's the whole--








Now, if you were able to design a program under 
law, a sponsorship of government, how would you structure 
it? 
MR. CLARK: In San Francisco, now I can only 
talk about my community, I basically think it has to be 
community-based. 
22 
SENATOR WATSON: Where in the community? 




MR. CLARK: No, I would have it street-based. 
has locations within clinics and also out in what 
6 call the methadone buses because they also do low-
threshold methadone; the ones that work are the ones that 
8 ar out in the street. 
9 
10 c 1 
I would have it street-based. I would have 
ally appropriate, ethnically appropriate education 
that gives you the outreach workers. I think it's 
12 a opriate to have a number of people that are 
13 recovering. one thing that I think is real important is 
4 to n up access to treatment. That when people talk 
genocide; there is genocide happening in this 
It is happening in the systematic denial of 
recovery services,and if you don't give them 
r access to recovery, a better economic opportunity, 
ter social availability of the options in their lives, 
y gain is going to be drugs. So, I think you have 
a lot of other stuff like giving available treatment 
so giving training and opening up economic 
tu ities for the people. Because, like, Nancy has 
neve worked. 








MR. CLARK: 32. 
SENATOR WATSON: Is she capable of working? 
Holding a job? 
MR. CLARK: Not as a heroin addict. 
SENATOR WATSON: Does she have other 
problems? 
MR. CLARK: I'm not a clinician. 
SENATOR WATSON: No, but do you know if she 
23 
9 has other problems. You said she's never worked. Is drug 
10 addiction a result of not working or --
11 MR. CLARK: It's mostly drug -related. Her not 
12 working is due to her being in the "life". She's also HIV-
13 infected although she's asymptomatic. The way she found 
14 out-- she said she would never have gotten tested; 
15 however, her boyfriend had been diagnosed and recently 
16 died, so that's how she came to know. 
17 I think that the other thing is I would make it 
18 extremely easy for the injection drug user to get tested 
19 because that, as an HIV pre-and post-test counselor, I 
20 l~now that knowing you're negative helps you change or gives 
21 you the motivator to change your behavior. Knowing your 
22 positive gives you a motivation to not infect other 
23 people. 
24 Also, my hesitancy about-- It's very hard for 
25 me to say somebody, "Well, you should know that you're 
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itive because there's AZT trials going on." But yet I 
2 know that it's very hard for an injection drug user to 
3 m those trials. So, it's sort of like, I don't know if 
4 without giving them access to greater primary health care 
5 for them knowing that they're positive doesn't mean 
6 they're going to get good health care. So, I would 
7 do that. 
8 So, it's increase the amount of treatment, get 
9 better access to health care, have it street-based, have 
10 it non-judgmental, treatment-linked,but not treatment-
based. 
12 SENATOR WATSON: Would you have a health care 
13 ovider as part of it or volunteers that are paramedics? 
14 MR. CLARK: I would like to see there being some 
sort of street- like, you know, there's a van, well it's 
than a van, it's an RV vehicle, that Haight Ashbury 
inic uses to do street triage, because often we'll 
e with abscesses on the street that won't go to 
emergency room because of the way they're treated 1n 
ency room for an abscess, and that's really the 
ace where people get medical care. So, I'd like to 
t happen. 
SENATOR TIATSON: You want an allied health 
person or a paramedical person there as part of the 




MR. CLARK: I'm not sure exactly of the 
professional level. 
treated. 
Yes, I think abscesses need to be 
SENATOR WATSON: You do probably very casual 
5 triage, but you need somebody there who can say it looks 
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6 like you have jaundice, you know, get thee to the doctor. 
7 MR. CLARK: Exactly. 
8 SENATOR WATSON: Okay. 
9 MR. CLARK: When you consider the costs of 
10 treating an HIV infected person, this is a cheap 
11 in terven ti on. I mean it can be done at the rate it's 
12 being done now in San Francisco. 
13 SENATOR WATSON: How are you being accepted 
14 in San Francisco in terms of government and law 
15 enforcement? 
16 MR. CLARK: Incredibly schizophrenic. A little 
17 bit bizarre. The Department of Public Health, Doctor 
18 Werdegar will present and speak in favor of needle 
19 exchange. The Mayor's Task Force on HIV supports needle 
20 exchange. We know that the Board of Pharmacy in the state 
21 of California supports needle exchange. The California 
22 Medical Association supports needle exchange. But yet, 
23 that important public health intervention falls into the 
24 hands of what could be categorized as rank amateurs. We 
25 have some expertise that we bring to the issue,but we 
1 bring it out of our experience and our commitment, not 
2 that nobody ever said I could do this, but I do it. 
3 The police basically, because of the threat of 
4 needle stick on the street, they're happier -- If you 
5 notice between the two slides, the ones in the beginning 
6 where we were showing syringes at the beginning of our 
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7 intervention. They were incredibly funky items that were 
8 almost entirely uncapped. When you look at the end almost 
9 all of those syringes are capped and they're in much 
10 tter shape. So, the police, the beat cop, often feels 
11 that they're at less risk because if an injection drug 
12 user does have a syringe it's most likely to be capped. 
13 That information came mostly out of the Tacoma police 
14 department, though we've had similar kinds of -- We've had 
15 beat cops salute us on the streets while we're doing what 





sort of, this is a very important 
Internationally you go and you hear about 
19 it,and then it's left to us to do. 
20 SENATOR ~ATSON: Thank you. I'm going to 
have to move this along a little quicker because we're 
be hi 
23 MR. CLARK: Okay, right. 
24 SENATOR WATSON: We do appriciate the 



























MR. CLARK: Okay, thank you. 
(Witness was excused.) 
SENATOR WATSON: I'd like to ask Doctor 
Michael Smith and Mark Madsen to come up. Doctor Smith is 
Chairperson of the Chemical Dependency Committee for the 
California Medical Association, and Mark Madsen is the 
Physician Education Department Manager, California Medical 
Association. 
STATEMENT BY MICHAEL SMITH, M.D. 
DOCTOR SMITH: Thank you, Senator Watson. I come 
here wearing several hats today. I suppose one of them is 
the official hat as a member of the California Medical 
Association, as the Chairman of the California Medical 
Association Committee on Chemical Dependency, and as a 
representative from the California Medical Association to 
this hearing to present to you the California Medical 
Association policy on clean needle and syringe exchange. 
I also come as a physician who treats patients 
with Acquired Immune Deficiency Syndrome, AIDS. The 
gentleman who preceded us provided an eloquent discussion 
of some of the tragedy that we witness in dealing with 
AIDS and some of the costs in human terms that we have and 
we see on a daily basis in dealing with AIDS. 
You and legislature know somewhat about our 
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ts, budget constraints and what goes on in the 
ex nse of caring for people and, in particular, caring 
3 for e with AIDS. It's an enormous expense. I'm not 
4 goi to review that at this time,but the expense is more 
5 tha It's time lost from work; it's the amount of 
6 rsi care required; it's the shortage of hospital beds; 
7 it's physician fees; it's medications that are incredibly 
8 ex nsive, and it's an ongoing process. 
9 We, at the California Medical Association, feel 
10 that with the policy that I will present to you in a 
moment, we can reduce the risk of intravenous drug users' 
12 igh-risk behavior. Mark Madsen, who is here with me, is a 
13 staff person from the CMA, and will provide for you some of 
statistics that he has put together and some of the 
ience from other needle exchange programs. We need 
where we, in California, are in the AIDS 
where other people have been, and where we may 
o forbid. 
Education, intervention and awareness in the gay 
on in San Francisco and elsewhere in the state of 
seems to have made a significant difference in 
behavior in those groups. We feel that the 
oach can be made in the intravenous drug users, 
we need to bring into this scenario one further 







I'm going to read to you now, if I may. You may 
have up there a copy,and if you don't,we'd like to pass to 
you now the CMA policy. 
SENATOR WATSON: Is it short? If you'd like 
to summarize rather than read it 
DOCTOR SMITH: It's fairly short. It's half a 
7 page. 
8 SENATOR WATSON: Very good. 
9 DOCTOR SMITH: "The CMA supports needle and 
1o syringe exchange programs to reduce transmission of HIV 
11 infections among intravenous drug users with the following 
12 caveats: Since we are concerned that such a program might 
13 be incorrectly perceived to be a complete solution, we 
14 feel that it is not. The California Medical Association 
15 believes needle and syringe exchange programs are likely 
16 to be effective only when part of a comprehensive approach 
17 which includes, (1) priority on treatment programs for 
18 opiate and stimulant users, (2} the use of outreach 
19 programs for hard-to-reach addicts such as was just 
20 presented to you. We feel that these people should be 
21 referred, but not linked to treatment. That there should 
22 be training on safer injection practices and the use of 
23 bleach for sterilization. At the same time, we feel that 
24 these people should be counseled on safe sex and safe sex 
25 practices. We feel that if we're going to be providing 
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i ec ion equipment, we should be sure that we are 
i safe injection equipment. we feel that we 
ovide voluntary, confidential and anonymous HIV 
4 and counseling and medical follow-up for infected 
5 and their sexual partners. We feel there should 
idential counseling, testing and appropriate 
7 tment programs in jails and prisons as another source 
8 of frequent IV drug use. We feel there should be social 
9 services to support families of the HIV-infected drug 
10 s, and we feel that this program should be evaluated on 
ongoing basis. we feel that community, both particular 
ommunities that are involved and the community at large, 
be involved in decisions as how this program will 
arried out." 
There are studies, as I mentioned, which Mark 
esent. I'll ask him to speak at this point and 
o a brief summary when he's through. 
STATEMENT BY MARK MADSEN 
MR. MADSEN: Thank you for having me here, 
Watson and members of the Committee. Let me 
u, if I just might momentarily, the packet of 
on I gave you. The first one which holds 
ing is the AIDS Advisory,and if you'll notice the 
was July 1989 that that was published. That was 
oximately two years of really looking at the 
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issue and seeing where the literature was taking us and 
2 what kinds of results we're seeing from the programs going 
3 on, some underground and some condoned by government. 
4 The needle exchange policy which Doctor Smith 
5 has just read to you comes next. It was just adopted by 
6 the council in November of this year,and I
1 ve included for 
7 you the references, all of which come from the Montreal 
8 International AIDS conference. I'm sorry about the 
9 reproduction, but they're still readable; all of them 
10 showing positive results of needle exchange. 
11 I also included for you on the buff paper the 
12 San Francisco Medical society's policy on needle exchange 
13 as well as the AIDS Foundation. And then, an excellent 
14 editorial review of needle exchange programs throughout 
15 the world by Gerry Stimson that really provides a 
16 framework for understanding the whole notion behind needle 
17 exchange which is somewhat -- Really we should be talking 
18 about HIV prevention programs which include clean needle 
19 and syringe exchange. That's the basis of the CMA policy. 
20 It's just one aspect of HIV prevention. That also 
21 includes a morbidity/mortality weekly report that talks 
22 about a program in Boston called Project Trust. And, to 
23 let you know that obviously the U.S. Public Health 
24 Services sees needle exchange as something viable and 







Although some of you know me as the AV 
today, I come to you from CMA, having spent the 
ars working with CMA Task Force on AIDS, 
virtually the entire packet of policies that 
its official position paper. The 
exchange is the latest piece to that puzzle. And I 
emphasize that it really is on the programs that 
as important for HIV control. 
I'm going to forego talking about statistics in 
led way because there are many more people here 
to speak,and they have a much better handle on the 
istics then I do. 
Let me just say a few things. Why is it CMA 
we felt it was important that CMA take a 
role here to provide medical and scientific 
su rt an overall HIV prevention program which 
needle exchange. A tendency is, as we all know 
, to emotionalize the issues surrounding the HIV 
One of the major forces here, and we felt to be 
or e, would be to provide that data and to help 
onalize some of it and to help provide guidance 
rams that are going on around the country, 
u arly in California obviously, at the local and 
ernment. 
As I said, we've studied the issue for more than 
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two years. Needle exchange is not the whole answer, just 
2 part of the program. As I said, it needs to be part of a 
3 larger program. The state of HIV infection now in 
4 California is what I would call at a window of opportunity 
5 that's closing fast. In the literature that I've given 
6 you,you can see what's happened in New York and New Jersey 
7 where that window of opportunity has closed. They started 
8 out somewhere with a five to fifteen percent HIV infection 
9 rate among IV drug users,and it increased to 30, 40, 50 
10 percent. It's now at 70 percent. There is no program for 
11 needle exchange there that's going to have a big impact 
12 like it can in California. We are now looking at the 













Doctor Werdegar, I'm sure, will talk about 
statistics in San Francisco, but in the beginning we saw 
somewhere less than five percent infected,and now we're up 
to somewhere around 15 to 17 percent infected. I don't 
know that we ever got data out of New York City that 
showed something less than five percent. The moment we 
started to look, it was around 15 to 20 percent. That's 
where we are right now. We've got a good look at it. 
We've been able to follow, and in San Francisco 
particularly, the statistics on who has been getting 
infected. 
Most importantly, I think, the people who are 
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1 g i to be affected by a comprehensive program are the 
l ers, the sexual partners, the children of IV drug users, 
3 become infected during that time when an IV drug 
4 user was not considering recovery as an opportunity for 






You cannot communicate with these groups of 
e, IV drug users, in the same way that you do with 
rson who is looking to buy an automobile or looking 
10 to find out what politics are going on in the state. They 
11 d read Time Magazine. They don't watch TV. Late 
12 TV maybe. They oftentimes don't have TV's. There 
to be a way of communicating with them. We feel the 
exchange program is the incentive to get them to 
to offer them opportunities,and that's really the 
the CMA policy today. 
SENATOR WATSON: Well, let me just ask you 
policy. Would CMA support the syringes being 
thout a prescription? 
MR. MADSEN: That's a specific question. Sold? 
l cy talks about needle exchange, not someone coming 
buying a syringe, off the street wanting to buy a 
we feel it's important that exchange be a part 
You need to be able to demonstrate that you're 


























misperceived that someone could come in and buy, for fear 
that we might get sort of an attitude that somebody is 
just experimenting with drugs, they could just come in and 
buy a needle. I don't think that's what we meant by the 
policy. 
Doctor Smith you might like to comment. 
DOCTOR SMITH: Well, I think that's part of it. 
The other part of it is that we want to intervene with 
these people at each time that we see them and that 
intervention doesn't have to be "we're taking you off the 
treatment"; that intervention can be you're using cleaner 
techniques, you're cleaning up your act, you're getting 
your life together. You use the counselors,and they can 
be at whatever level we decide is appropriate on the 
street; most importantly people who are "12 stepping", 
people who have been there and are now getting well or who 
are on the road to recovery and who can say to the 
addicts, "I've been where you are, I've walked in your 
shoes, now walk with me."; and that's effective. It isn't 
necessarily effective the first time you see the person; 
it may be effective after a couple of months of trust. 
SENATOR WATSON: It's like the alchoholic 
anonymous mode. 
DOCTOR SMITH: Absolutely the same thing. 
SENATOR WATSON: Okay, let me ask you 
ng about this particular advisory position. It 
this advisory group has prompted city public 
authorities to announce that they will go to the 
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4 state and seek permission to institute a program of needle 
5 ex How committed is CMA to that proposal, that 
6 cone ? Would CMA, if such a bill were introduced, a 
7 licy oposed, would CMA be willing to come and be an 
8 adv ate and lobby us for that particular policy? 
9 MR. MADSEN: Yes, they would, and that's exactly 
nted to set the foundation and the framework with 
the le n needle exchange policy program. 
2 SENATOR WATSON: So, you're not talking about 
13 se li needles so we'll drop that piece off. 
MR. MADSEN: That's a very specific kind of 
If a program was developed and a component of it 
es were sold and there somehow was an 
10n model, it wasn't just selling needles, then 
y would have to look at that and evaluate that and 
it to our policy. 
WATSON: I just threw that out. 
MR. MADSEN: Let me just give you a couple of 
cs that I think nobody else is going to mention 
That was part of the California Department of 
Services family of surveys they conducted in 1987 










statistics. 128,000 adult Californians reported needle 
use during some time in their lives. 45,000 reported 
needle use during 
SENATOR WATSON: Illegal use? 
MR. MADSEN: Illegal use, needle use, IV drug 
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use. 45,000 reported needle use during the last 12 months 
and 30,000 reported needle use during the last 30 days. 
SENATOR WATSON: These are all potential 
persons with AIDS? 
MR. MADSEN: All potential with HIV infection 
11 and the ability to pass it on through their sexual 
12 partners 













adults who have used, if there's any number that shows 
those have been identified as having HIV? 
MR. MADSEN: No. 
DOCTOR SMITH: Senator Watson, that was 128,000. 
SENATOR WATSON: Yes, 128,000. 
MR. MADSEN: No, in order to conduct a survey of 
this kind there has to be complete confidentiality and 
anonymous,and so there's no way to ascertain other data 
that you might want to know. 
SENATOR WATSON: This is high-risk behavior. 
MR. MADSEN: It's high-risk behavior. Then 
let's look at 191,000 women having had at least one IV 
4 
dr ~using sexual partner sometime during 1987. We also 
e 32,000 men having had sex with a partner who used IV 
drug use. So you can see we begin the progression. 
I'll just close with one statement which I've 
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5 heard and I've adopted. I can't help but say it at a time 
6 ike this and that is, "Just say no" to the IV drug user 
7 i 5 l i k e " Have a n ice day" to the c 1 in i c a 11 y de pre s sed • I t 
8 doesn't work. 
9 SENATOR WATSON: I think we all picked up on 
a ly on. 
11 All right, did you want to conclude, Doctor 
12 Smith? 
13 DOCTOR SMITH: Well, I just want to say that in 
4 studies that have been done and we have reviewed, 
e are four facts that have come out. (l) Needle 
programs do not increase IV drug use, (2) they do 
se re rrals and stays at treatment programs, (3) 
there is a theoretical reduction in the risk of HIV 
which has not yet been borne out by the long 
5 ies and (4) that there is a definite reduction 
h h-risk behaviors. They use clean needles, or they 
their needles or they don't share their needles. 
facts are proven in studies. 
SENATOR WATSON: You got your point over. 
DOCTOR SMITH: Thank you. 
2 
3 
SENATOR WATSON: I certainly thank the two of 
,and I am very pleased to know that CMA has looked at 
the issue, has researched it, and has taken a position. 
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I 
4 want you to be ready to be called on because I think that 
5 this is going to grow. I see it as a desperately needed 
6 program, because of the statistics, Mr. Madsen, that you 
7 just gave. We don't even know who in this population, but 
8 I would expect that a very high percentage of the 128,000 
and the 191,000 are potential HIV positive. So, thank you 







MR. MADSEN: I just want to let the audience 
know that I'm going to put packets of information over 
here for their use. 
SENATOR ~ATSO~: Very good. 
(Witnesses were excused.) 
SENATOR WATSO~: Doctor Werdegar, who is the 
8 Director of the Public Health Department, City and County 
g of San Francisco. 
20 STATEMENT BY DOCTOR DAVID WERDEGAR 
2 DOCTOR WERDEGAR: Senator Watson, thank you very 
22 much for holding these hearings and for inviting me to 
23 ticipate. I'm going to share my brief presentation 
ith Doctor Patricia Evans who is the Associate Medical 











and AIDS expert. 
SENATOR WATSON: Doctor Evans, welcome. 
DOCTOR EVANS: Thank you. 
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DOCTOR WERDEGAR: In my testimony I've attached 
a r t prepared by Doctor Evans for our San Francisco 
Health Commission. 
SENATOR WATSON: Do we have a copy of that? 
DOCTOR WERDEGAR: I have them here. 
SENATOR WATSON: Okay, can I get one of the 
sergeants to pick them up, please? 
DOCTOR WERDEGAR: In this report Doctor Evans 
summarized the world's scientific literature 
ints out as previous speakers have that the weight 
tific evidence shows that needle exchange 
, when part of a comprehensive drug abuse and AIDS 
ram, are effective, that they cause no 
ncrease in substance abuse, and are really 
for AIDS prevention. 
Yo asked earlier and I'll just say 
cally, "How are needles disposed of? 11 • They 
sed of the way hospital infectious wastes 
of which, in most communities, is by 
In California there are special rules for 
sing of infectious waste. 



























DOCTOR WERDEGAR: Recycling the needles? No, 
because they're filled with blood and other things. The 
simplest way is really to ensure they're --
SENATOR WATSON: The i~~ense heat will kill 
all the germs? 
DOCTOR WERDEGAR: Yes, the best way is just to 
be rid of them and use new products. 
SENATOR WATSON: What do they do with the 
waste? 
DOCTOR WERDEGAR: They are reduced to ashes 
eventually. 
SENATOR WATSON: What do they do with the 
ashes? 
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DOCTOR WERDEGAR: The ashes can be safely put 
into ground fill or whatever after it's been-- well, once 
it's been reduced to ash you've got a safe product to 
dispose of. 
These are the some of the points that I want to 
make. As the head of the Health Department in San 
Francisco for the last five years, I direct health 
activities in our community that has the worst AIDS 
epidemic in the country. We not only fight the AIDS 
epidemic,but simultaneously,the drug abuse epidemic,and 







te insurance or no access to primary care. Those 
idemics are very much intertwined. 
The needle exchange program is just part of an 











criticisms,but when it's part of a comprehensive program, 
it's very hel ul. My concern really has been that the 
clock is ticking, and we know from epidemiological studies 
that in East Coast communities,IV drug abuse, AIDS, has 
spread very rapidly so that in the IV drug abuse community 
in New York City, Newark, New Jersey, two-thirds of IV 
drug users are already HIV positive and that their 
partners are infected and their children are born infected, 
and it's really a social disaster. The fact is that in 
California, the rates of HIV among IV drug users is still 








around five percent. In San Francisco, I'm sorry to say, 
as h gh s 15 to 20 percent. These are not like the 
Ea tern figures,and we have a chance to do something about 
it,and we need very vigorous programs that include all of 
the things that have been described by Mr. Clark, by the 
evious speakers from the CMA, and which you'll hear more 
abou . 
If we had a vigorous program and that includes 
exchange, bleach outreach, access to health care, 
















about the epidemic. 
Another point I want to make -- So, time is of 
the essence, and that means that legislative time is of the 
essence. 
Another point I want to make is this--,very 
simply, that right now if we had utter unanimity, if 
everybody agreed that having needle exchange programs was 
beneficial for health, social welfare and for our 
community, there is no mechanism up in San Francisco for 
authorizing pilot needle exchange programs. The State 
Health Director, legal counsel says the State Health 
Director is not empowered to authorize and approve such 
programs. Legal counsel says the same. You'll hear this 
from Mr. Cavanaugh when he speaks for the State Board of 
Pharmacy. I testify at their hearings and heard their 
15 discussions. The State Board of Pharmacy endorsed the 
17 concept of needle exchange as part of a comprehensive 
18 program unanimously, and their legal counsel again said 
19 that they are not empowered to authorize pilot needle 
20 exchange programs, any kind of needle exchange programs. 
21 So, we have no agency of government in 
22 Sacramento that can authorize such programs and make them 
23 legal so that health departments like my own could conduct 
24 them. We would conduct street-based programs. We admire 

















I have talked to our police chief and told him how 
much I admire their work and what I think it is doing 
positively for our community. But I as a health director, 
our department, cannot initiate such programs because we 
need permission from Sacramento,and nobody in Sacramento 
can give it to us. 
So, even if the legislature did not decide 
whether the needle exchange is of benefit or not, well the 
government need not decide if it's of benefit or not, I 
think at a minimum what the legislature has to decide is 
that there should be some respected agency of government, 
the department of health or the pharmacy board that could 
have the authorization to review the proposed pilot needle 
exchange programs, evaluate them,and make them legal. At 
15 the moment,we have no mechanism to do that. 
16 
17 
That, in a sense, is my bottom line. Because 
our health commission very carefully reviewed this whole 
18 issue. We had scientific testimony, public testimony, and 
19 the San Francisco Health Commission said that they want to 
20 go ahead with pilot needle programs as soon as they become 
21 legal, and they, in fact, urged that I, as the Director and 
22 our Mayor and Board of Supervisors, seek what help we 
23 could from the state legislature to make such programs 
24 legal. I've attached a beautifully written resolution 
25 with all of its very pertinent "whereas's" in the 
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testimony from the San Francisco Health Commission. 
2 One of our commissioners, and your staff asked 
3 me about this, one of our Commissioners, Commissioner 
4 Gray, was against the program. I guess my comment briefly 
5 -- I have high respect for Commissioner Gray. She is 
6 loyal to her causes and her community. Her principal 
7 concern was that if we had needle exchange programs,that 
8 right now they're not legal, and in a memo that she wrote, 
9 and I believe you and your staff have copies, you'll see 
10 that one of her principal concerns related to the legality 
11 of such programs. I think if we had legal programs, 
12 because we had state authorization to conduct them, 90 
13 percent of her concerns would go away. 
14 There was no question that she was also 
15 concerned about the views in some of the black churches 
16 that needle exchange might be viewed by the community as 
17 condoning the use of drugs. The answer, of course, and 
18 it's an education process working with the black ministry 
19 and the black churches, is that actually the availability 
20 of needle exchange programs in the long run does the 
21 opposite. It opens new avenues for access to health care; 
22 new avenues for access to drug treatment; new ways of 
23 saying to the drug addict, "We care about you and want to 
24 take care of you, " and in that sense it really doesn't 
25 encourage or condone; it provides a way of offering 
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1 relief. I think we have to work with the black churches, 
2 the black ministries. It's very important if we're going 
3 to reach into the community,and we have been involved in 
4 dialogue with the churches on just this point. 
5 So that's the gist of my testimony. Most of it 
6 is written. I would emphasize that the weight of 
7 scientific evidence certainly now favors the needle 
8 exchange for AIDS prevention. Some have said, "Is the 
9 proof absolutely conclusive?". In science the proof of 
10 anything being absolutely conclusive takes a long, long 
11 time and we don't have the luxury of a long, long time. 
12 The weight of evidence, there's no question where that is. 
13 Time is of the essence. We've got a five to fifteen 
14 percent prevalence rate; they've got a 65 to 70 percent 
15 rate on the East Coast. We can spare a lot of grief and 
16 suffering and social disaster if we act quickly. At a 
17 min , the legislative help we need is to give to some 
18 re ted agency of government, whether it's one agency, 
19 the Health Department or the Pharmacy Board, or some 
20 committee that includes those two and the University of 
21 ifornia, but we need some agency up there that can say 
22 "ok 11 to a pilot program if it's designed properly and if 
23 there's a proper way evaluate it. 
24 
25 p lot 
SENATOR WATSON: Let me ask you this. Of a 
ograrn you'd have to have an evaluation, pre-and 
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post-testing. How would you set that up? 
2 DOCTOR WERDEGAR: I'm going to ask Doctor Evans 
3 to tell you about that. 
4 SENATOR WATSON: Okay, very good. 
5 STATEMENT BY DOCTOR PATRICIA EVANS 
6 DOCTOR EVANS: I'll skip to that and go 
7 immediately to that. 
8 My name is Doctor Patricia Evans and it is a 

















been awhile, but I'm pleased to be here and honored also. 
In terms of evaluation, I have for you here an 
example of a protocol which certainly could be used. This 
is a scientific protocol which was pulled together by 
myself at the request of Doctor Werdegar, and I've also 
received some input from some of the researchers who are 
involved with intravenous drug users in the San Francisco 
area; so I'll pass this out. 
In terms of the research questions, you really 
need to look at what specifically are you interested in, 
because that will determine what the cost of the program 
is. In San Francisco, Doctor Werdegar's and other 
researchers in San Francisco have indicated that there's 
about a three percent seroconversion rate per year amongst 
intravenous drug users. If you want to prove the needle 
exchange effects that you're going to have to have an 
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1 extremely large sample size which is going to increase the 
2 cost of the program. 
3 We do know the evaluations from around the world, 
4 as well as here in the United States,have looked at self-
5 report behavior change,and so we certainly can look at 
6 those particular parameters, and that becomes less costly 
7 than just looking at HIV seroprevalence and seroconversion 
8 rates. 
9 We can also look at secondary data set analyses 
10 of other parameters such as, hospital admissions for 
11 bacterial endocarditis for intravenous drug users, 
12 admissions for abscesses in terms of intravenous drug 
13 users as well. so it really depends upon what sort of 
14 research questions you want to ask as to which is the best 
15 way to set up. I think that what I have provided to you 
16 will really look at behavior change over time -- between 
17 time one, t two, time three and time four --
18 SENATOR WATSON: Well, one of the things that 
19 we'd be interested in seeing is if our needle exchange 
20 program is working for an individual; does that individual 
21 test HIV positive? 
22 DOCTOR EVANS: The test should certainly be 
23 offered to anyone coming into the program,and what I have 
24 proposed there is that anyone who does participate in the 
25 evaluation -- because I think there is a difference 
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between participating in the evaluation component versus 
2 those who are in the program exchanging needles. You need 
3 to take a random sample of those participating in the program 
4 to really do a good evaluation. HIV antibody testing 
5 should be offered to them. Individual people should not 
6 be coerced to take the test, though. 
7 SENATOR WATSON: See, our opponents, and I 
8 was just reading the letter here, feel that in some way 
9 it's making illegal activities or promoting illegal 
10 activities. In Ms. Gray's letter there's some reference 
11 to making the use of drugs or preventing the use of drugs 
12 or making them legal if you're going to make the exchange 
13 program legal. 
14 DOCTOR WERDEGAR: Well, as you know, I talked to 
15 Commissioner Gray on this point quite a bit as has Pat, 
16 because at the moment there is no way at the Health 
17 Department, she's one of our Health Commissioners, 
18 conducting the program legally because we have no way of 
19 getting the authorization from any agency of state 
20 government; she feels that exchanging needles encourages 
21 people to engage in illegal behavior. That's why I said 
22 that I think 90 percent, maybe not all, of Commissioner 
23 Naomi Gray's objections are solved by our being able to 
24 put such programs on a legal footing by having appropriate 


























SENATOR WATSON: And I think one of the ways 
of doing that is by showing some data that says that it 
does have a positive effect, at least this percentage 
has not developed HIV yet. 
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DOCTOR EVANS: That's correct. The other thing, 
too, is that we are always following the cart before the 
horse, it seems, because everyone -- the arguments that I 
get are that needle exchange has not been proven, but how 
do you ever prove it unless you evaluate the program? So 
you need to evaluate the program so you can say if it is 
or is not effective. 
We do know that it is effective in terms of 
positive behavior change. That information is available 
from around the world. It has also become available here 
in the United States. Don DesJarlais, who is evaluating 
the program up in Tacoma, as well as the program in New 
York City, but we need to evaluate other programs as well, 
too. 
The other thing that I'd like to point out is 
the fact that instead of talking about needle exchange as 
a needle exchange, you really need to talk about it as 
another form of outreach because that's how I really see 
needle exchange. It is another form of outreach activity, 
to reach a group of individuals who have been difficult 
for the current system to reach. It's really our problem 
that we cannot reach them. It is not they who have 
2 problems. It's really us who have the problems reaching 
3 out to them. 
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4 This is another form of outreach,and literature 
5 certainly does indicate that a number of people, and in 
6 fact, there was a study in England that shows there was 
7 about a third of those who participated in the needle 
8 exchange had never been in contact with the substance 
9 abuse treatment programs in that country. So, again, we 
10 have access to a patient population which we currently do 
11 not have access to and we won't be able to give any 
12 messages to no matter what we do, unless we try different 
13 forms of outreach. so that's another point that I would 
14 like to get across. 
15 The other thing is that you talked about needle 
16 exchange in terms of what it should really look like. 
17 And, again, if I look at it in terms of outreach, there 
18 are other aspects to those outreach activities which need 
19 to be included because then you can clearly see where and how 
20 this outreach activity will occur. You can also talk 
21 about the scope of the interactions, such as discussions 
22 of proper needle hygiene as well as safer sex. There can 
23 also be a risk assessment done on individuals, not just in 
24 terms of medical care, but also in terms of legal housing, 
25 nutritional needs, psycho-social needs, because this can 
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1 be part of the outreach activity, as well as referrals to 
2 the proper agencies which requires that those who are 
3 participating in outreach, in terms of the outreach 
4 workers, need to be properly trained. 
5 Then there's the whole issue of advocacy that needs 






talked about a comprehensive program for substance 
abusers. I have given to you a sample protocol on the 
very last sheet also indicates what this comprehensive 
program really should look like. There are a number of 
areas which I have included in there, and one of them which 
12 has been discussed before is treatment on demand. We're 
13 really talking about lots of different types of treatment 
14 modality, not just methadone, but different types of 
15 treatment modality for individuals. We're also talking 
16 about prevention of needle-associated transmission,which 
7 would include outreach activities not only for bleach and 
18 condoms, but also for needle exchange. 
19 re would also be general public educat1on 
20 ause one of our biggest problems,as I see it, is the 
21 fact that the public is ill-informed about the whole issue 
22 of addiction and substance abuse and what we're trying to 
23 do with needle exchange. There needs to be general public 
24 education, as well as provider education. 















information about substance abuse and addiction when I was 
going through medical school. If I did not receive it, 
what about those individuals who went before me, and even 
after me,who still do not know that much about addiction 
and substance abuse. 
Then there's the whole issue of research in 
terms of this comprehensive program to make sure that all 
of the components that we're talking about really do work 
effectively. What can be done to modify them to work more 
effectively and efficiently,and how can we best reach the 
populations what we're really talking about. 
SENATOR WATSON: Okay. 
DOCTOR EVANS: So thank you very much. 
SENATOR WATSON: Well, I want to thank you 
15 for your fine work. I mean, you've given us an outline 
16 here that we can go back and take a look at and do some 
17 additional research. I think this proposal that we're all 
18 talking about this afternoon has to be handled very 
19 delicately. I can see the reaction of commissioner Gray, 
20 and it's a reaction that's probably shared by many. It 
21 sounds like an excessive program that exacerbates the 
22 illegal aspects rather than programs that can help. The 
23 way we bridge that is to get good information out there, 
24 statistical information out there, the benefit of whatever 
25 research data we already have, and people speaking to it, 
credible people. 
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I think it will help us greatly to have 
2 CMA sending their advisory bulletin out and to be talking 
3 about this and to hold hearings when they have their 
4 statewide convention. To speak to the press. This is 
5 what's going to bring this about. 
6 So thank you for your good work. We apprec1ate 
7 it and it's good to see you. 
8 DOCTOR EVANS: Thank you. 
9 
10 
(Witness was excused.) 
SENATOR WATSON: All right, we've got to move 
11 on a little quicker. 
12 Doctor Flynn, M.D., Medical Director with the 
13 university of California Davis Medical Treatment Center 
14 for AIDS. 
15 STATEMENT BY DOCTOR NEIL FLYNN 
16 DOCTOR FLYNN: Thank you, Senator Watson. I 








Can you summarize this? 
I certainly can. 
That would be very helpful. 
I would like to give you a 
22 perspective of a medium size city, that is Sacramento, 
23 where one would think that the IV drug problem and AIDS 
24 problem is not that great compared to San Francisco or Los 
25 Angeles. But, I'd like to let you know that there are 
approximately 8,000 IV drug users in Sacramento, and 
2 you're very familiar with the city of Sacramento. 
3 Of those, about three to five percent are 
4 currently infected,and you'll see on my bottom table 
5 there, comparison among San Francisco, Los Angeles and 
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6 Sacramento for seroprevalence over the last several years. 
7 The striking things are, as Doctor werdegar and Doctor 
8 Evans have pointed out, that San Francisco was where we 
9 are today in Sacramento about three to four years ago and 
10 are now up to 15 to 20 percent infected level. 
11 If one superimposes these curves on the curve of 
12 New York City in the years 1978 through 1983, it is 
13 identical and it ends up at 70 percent infected. We are 
14 undergoing the same rate of spread currently in San 
15 Francisco as was documented in New York City. 
16 There are currently programs for bleach use 
17 disinfection,and what I'd like to do is give you some data 
18 on 1400 IV drug users who we've interviewed in Sacramento 
19 on the use of bleach and other high-risk behaviors. These 
20 individuals are interviewed for one hour each, one on one 
21 in a private setting. We've now done 1,400 of them,and 
22 they are educated for that hour as they are asked 
23 questions about their drug use. At the end of that time 
24 period,they are given written materials, condoms and 
25 bleach,and we pay them to come back about four months or 
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longer from that time. we pay them $25.00 in order to get 
2 them back, and we have currently about a 30 percent return 
3 rate for requestioning. 
4 The things I'd like to point out to you in the 
5 second table among the high-risk behaviors are that 
6 initially 70 percent of individuals obtain their needles, 
7 the ones that they used when they shot up last time, from 
8 either a connection or friends or peers. So you can 
9 understand that those needles are probably used,and those 
10 syringes have probably been used before. After education 
11 that fell to only 57 percent. It's still high. 
12 Additionally, those who rinse their 
13 paraphernalia in either bleach or liquid detergent or 
14 alcohol, whatever, went from 54 percent who never used 
15 I'm sorry, the second part is frequency of sharing their 
16 needles went from never or sometimes, that is rarely 
17 sharing their needles, 54 percent went to 74 percent. so 
18 we made progress there with an intensive educational 
19 ogram. Some progress, but certainly not enough. 
20 Of those who often, usually,or always share went 
21 from 47 percent to 19 percent of the follow-up people. 
22 One last point with regard to the third wave of 
23 HIV infection, the first one being gay men in this state, 
24 the second one being IV drug users, and the third wave 







second and third waves are potentially preventable at this 
point in time. 
Look at the last three entries on that table. 
One sees that they rarely, if ever, use condoms, and that 
behavior does not change after education. They do not 
like condoms. It's one thing to disinfect the needle. 
7 That doesn't interfere with your pleasure at all, but they 
8 do not use condoms, suggesting that our educational 
9 efforts are ineffective in terms of condom use; and that 
10 once IV drug users get this virus, they will transmit it to 
11 their sexual partners and their children, resulting in the 
12 third wave of infection, such as has been seen already in 
13 New York City where one in sixty babies born is born with 
14 H I v , two perc en t of b ab i e s born . 
15 I will simply summarize my recommendations and 
16 say that they have been already articulated by the 
17 previous speakers. You have a list there of what we, in 
18 Sacramento, after two years of studying this issue have 
19 felt some basic components of needle and syringe exchange 
20 to be,and we agree with others that it should be only a 
21 part of a very comprehensive and very well-funded program 
22 for prevention of HIV spread. 
23 I would like to also state that while I agree 
24 with the previous speakers on not necessarily linking, but 
25 making available drug treatment for people in these 
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1 programs, the issues of AIDS spread, HIV spread and drug 
2 addiction must be separated in our minds. we can do 
3 something immediately about the spread of HIV for 
4 relatively little money. We cannot at the same time 
5 expect to do very much about IV drug use. We can begin 
6 the process, but these two issues must be separated in our 
7 minds. I think this is one of things that our opponents 
8 of needle exchange fail to do in their minds. To them 
9 it's okay, apparently, if IV drug users get the virus so 
10 long as we don't do anything to condone or make the 
11 appearance of condoning IV drug use. Those issues must 
12 separated. AIDS is too large an issue and too important 
13 to be tied to success in drug treatment. 
14 Finally, I'll give you a summary of the 
be 
15 objections that our task force came up with. They are as 
16 the others have said, it is currently illegal. One of our 
17 law enforcement agencies, I think, would accept the fact 
18 of it becomi legal and would support us. The other is 
19 adamantly ainst the legalization of possession of 
20 para rnalia or of legalization of needle exchange 
21 programs. 
22 Secondly, the wrong message, and I think we have 
23 alot to do in the way that we phrase these programs with 
24 whether the wrong message gets out or not, whether it's 
25 seen as condoning drug use or not, we can phrase these 
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programs in such a way that they actually contribute both 
2 perceptually and actually on the street to decrease drug 
3 abuse and increase drug treatments. 
4 Finally, that there is no evidence currently 
5 that these programs will increase either drug use or make 
6 it more difficult for law enforcement to prosecute for 
7 illegal use of drugs. Another objection has been that law 
8 enforcement will lose a tool, that is, the criminal 
9 possession of paraphernalia law is a tool for law 
10 enforcement for bringing in a drug user,and our law 
11 enforcement people do not use it as a tool. They have 
12 told us that it would not result in fewer arrests for 
13 illegal drug use if they were deprived of the illegal 
14 possession statute. 
15 SENATOR WATSON: There are certainly a lot of 
16 safeguards that would be part of any public policy and 
17 just so that we can enforce laws and so we can keep down 
18 the growth so that we can prevent -- So all of these areas 
19 will take separate kinds of safeguards,so that we're not 
20 creating a larger problem than we're trying to solve. 
21 DOCTOR FLYNN: And I think it can be done. 
22 SENATOR WATSON: Thank you so much for coming. 
23 Did you conclude? 
24 
25 
DOCTOR FLYNN: Yes. 











appreciate the paperwork you've given us. 
(Witness was excused.) 
Cavanaugh, State Board of Pharmacy and 
, In er-Agency Drug Abuse Recovery Programs. 
STATEMENT BY JAY CAVANAUGH 
MR. CAVANAUGH: Good afternoon, Senator. I'm 
Jay Cavan from the California State Board of Pharmacy and 
our President, Glenn Yokohama is kind enough to join us. 
I'm really thrilled that we have an opportunity 
10 to t k wi you about this important issue. California 
11 Board of Pharmacy in 1988 reviewed some of the problems 
12 about hypodermics,and at that time,the Board felt, for a 
13 number of reasons, didn't want to move ahead on any 
14 recommendations for needle exchange. The two major 
15 reasons at that time were the information that we had been 
16 given was that this was primarily an East Coast problem, 







raid of sending the wrong message on drug 
se are legitimate reasons. 
intervening year, however, the Board went 
wed the issue scientifically. I remember 
21 rsonally over 200 scientific papers, some 3,000 
22 ng I mean talk about getting snowed with paper, 
23 but we wan to find out the truth. Truth is very 
24 important when people's lives are at stake. 
25 One of the things we saw was that we tracked the 
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1 outbreak of AIDS and intravenous drug users, not just in 
2 New York City, but outbreaks of AIDS in Stockholm, in 
3 Milan, Italy, in Bangkok, Thailand, in Edinborough and in 
4 other places, so the idea that it can't happen here just 
5 wasn't so. It just hadn't happened here yet. 
6 The other thing was, and I was persuaded to this 
7 because I'm an anti-drug person. I'm an appointee of 
8 Governor George Deukmejian,and I've spent 20 years 
9 fighting substance abuse, but I was persuaded that the 
10 posturing of being anti-drug is no longer important. The 
11 primary victim of the intravenous drug user who has AIDS 
12 is their child. 
13 Scientifically, there is no debate over whether 
14 we should have needle exchange. The World Health 
15 Organization, California Medical Association, California 
16 Board of Pharmacy, State Department of Health, on down the 
17 line, scientifically support needle exchange. 
18 The problem has not been a scientific one; it's 
19 been a moral question,and the moral question that I wish 
20 to raise, because everyone's danced around it and I'm 
21 going to address it very directly and that is, that the 
22 primary victims are the newborn infants of infected 
23 mothers. On what moral grounds can we say that in order 
24 to avoid giving a pro-drug message we will allow these 
25 people to suffer? It's not supportable. It's a 
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1 fundamental ethical question. 
2 That question was raised and presented in the 
3 Montreal International AIDS conference,and it certainly 
4 persuaded me. I don't want to suggest that anybody use 
5 drugs or continue to use needles. 
6 I know also that the scientific evidence showed 
7 four key points and these are them, mentioned before but I 
8 want to reiterate them because they're important that they 
g be on the record; (1) Needle exchange programs as part of 
10 an overall AIDS education and drug treatment effort 
11 reduced the spread of HIV, reduced the degree of needle 
12 sharing, did not result in any increase in people abusing 




SENATOR WATSON: Where was this research 
DOCTOR CAVANAUGH: Oh, this research has been 




WATSON: And where did it take place? 
DOCTOR CAVANAUGH: In England, a great deal of 
land. A great deal of it in Australia. You know 
21 Australia has needle exchange throughout the entire 
22 country whole country has needle exchange. They do 
23 it in the pharmacy. 
24 SENATOR WATSON: What's their growth pattern 


























DOCTOR CAVANAUGH: They have stopped AIDS. They 
have stopped it cold. They stopped it dead in its tracks. 
The same thing in England. Now in Edinborough they had an 
outbreak,but in the balance of Great Britain they were 
able to halt this geometric increase. 
You see, what happens, and it was eluded to 
earlier, the increase goes five percent, ten percent, 
fifteen percent and somewhere between fifteen and twenty 
percent, when fifteen to twenty percent of the intravenous 
drug users have the virus, right around there,a geometric 
curve cuts in and it skyrockets. Now they were able to 
prevent that increase in England. They were able to 
prevent it in Denmark, in Australia and in other areas 
where they implemented, not just needle exchange, but 
comprehensive efforts that included needle exchange 
programs. We're at that point here,so the research has 
been done throughout the world. Many, many papers have 
been published. No increase in drug abuse and most 
importantly, in every study that I read there was an 
increased number of individuals referred to drug abuse 
trea trnent. 
Now, if you're anti-drug and you want people to 
stop using drugs, how can one not support something that 
gets more people the help that they need? On that basis, 



























year. Those hearings included many of the same witnesses 
that you heard and many others. We reviewed many of the 
scientific papers and on a unanimous motion, the State 
Board of Pharmacy agreed to support a pilot needle 
exchange effort as part of an overall AIDS education and 
drug treatment program. 
The reason we put those caveats on it is we 
don ' t want to go will y n i 11 y saying , " Let ' s just hand out 
syringes to people"; we want to do this in a responsible 
way. 
That's basically my presentation. Glenn, do you 
want to add something? 
MR. YOKOHAMA: No, I wasn't going to add 
anything other than some of the speakers had mentioned, I 
guess, the Board of Pharmacy is looking for, I guess 
there's a co e of avenues of going, apparently. One of 
those avenues is legislature telling the Board of 
Pharmacy or the Department of Health Services that you are 
the ones t w ll be charged for evaluating pilot 
programs, for example, and I guess the other one is just 
through the legislative process where you get legislation 
to --
WATSON: Okay, let me just ask --I 
thought I heard you, Mr. Cavanaugh, say that the 










MR. CAVANAUGH: Yes, I read an interim report 
that was presented to Ken Kizer wherein they stated 
clearly that they were in support of a pilot program. You 
see, there are public and private positions that are being 
taken. 
SENATOR WATSON: Was it just a needle 
exchange or the AIDS Leadership Plan that they were in 
9 support of? 










SENATOR WATSON: They were in support of that 
overall comprehensive --
MR. CAVANAUGH: Yes, and in private 
conversations with folks, they do support it. What they're 
basically saying, to let the cat out of the bag, is how do 
we do this in a way so that we don't get creamed 
politically? And I believe that the way to do it is by 







support a needle exchange program that is done with the 
proper safeguards,and I think other conservatives-- I 
mean, after all, what's a conservative if you can't 
conserve life? And we have to support any effort that 
will help prevent these newborns from getting this virus. 



























Department supports the provisions of this plan or do they 
just support the report from the Advisory Committee? 
MR. CAVANAUGH: They supported the report from 
the Advisory Committee. 
SENATOR WATSON: Okay, so we would have to 
then find out if they support -- I had heard that they 
were opposed to a needle exchange program, but maybe with 
this kind of comprehensive approach? 
MR. CAVANAUGH: I think what's happening, what 
we're seeing here today, there is a consensus building in 
the professional community. When you have California 
Medical Association, California Board of Pharmacy, 
responsible, basically conservative organizations, saying 
please grant us the authority to oversee such programs in 
a responsible way, then that has to have some effect. 
SENATOR WATSON: I don't even know what 
conservative means when you are addressing this issue, 
when u say u're a conservative. That has no meaning. 
You've got to break it down for me. I think you're on the 
r t road. 
MR. CAVANAUGH: It means that I care about 
e, it means that this is a public health issue to 
me, not a political issue. 
SENATOR WATSON: Well, throw away the use of 







MR. CAVANAUGH: Yes, but the opposition to this 
plan is going to be a dogmatic one in my mind, and it must 
be overcome. 
SENATOR WATSON: And, they will present the 
moral arguments,and they have a place somewhere over here 
while we address what's actually happening today with 













argue it based on what we see is occurring among people 
within the society, and what is our responsibility to 
address from the health stand point. 
MR. CAVANAUGH: Yes, and senator, one point that 
hasn't been made. Addiction, I'm a molecular biologist, 
and from everything we know,an addiction really is a 
disease,and the intravenous drug user has, over the course 
of time, diminished ability to exercise sound judgment. 
Education in these cases, as Doctor Flynn points out, will 
not necessarily work. We cannot prevent these people from 
continuing their use. Now if they were the sole victims, 
morally you might say they made that initial choice; 






their children, and the members of the community, we're 
condemning those people to getting the virus, and there is 
no moral standing to do that. 
SENATOR WATSON: I think that your Board 


























what you said here. I think you have credibility. I 
think from the appointing power, you're there because they 
felt that you could present the case in a rational, 
reasonable, logical way; so do it. The more you speak out 
and the more you show the results of your research and 
your study and input from your advisory committee the 
easier it is going to be. 
You see, on the other side of a conservative is 
a lioeral, and that's me. The easier it's going to be for 
me to propose such a program. If we get it blocked up at 
the top, and I think you're going to understand what I'm 
talking about, then we've just had an afternoon exchanging 
ideas. I want this to turn into something real and 
certainly your Board can help. 
MR. CAVANAUGH: Oh, it must. 
MR. YOKOHAMA: By the way, I was going to say, 
Senator Watson, that the pharmacists, the CPAC as well as 
the California Society of Pharmacists, does have a task 
force that is trying to promote within the profession as 
well as in the community, some of the message that you 
ke about. 
SENATOR WATSON: I would like to invite all 
of you here, and particularly you two, I have a health 
advisory committee that's been ongoing for about 14 years 


























looked at needle exchange. We've looked at substance 
abuse as a whole,but I think, Jane, we should have one 
meeting dealing with just this issue because it's a cross 
section of all health providers and not only health 
providers,but third party payers, and all those who are 
interested in health delivery systems here in the state of 
California; and I feel that this is an area that is going 
to grow in terms of its visibility and our attention to 
it. 
MR. CAVANAUGH: I believe, Senator, the Board 
would support a bill that empowered the State Department 
of Health or the Board of Pharmacy --
SENATOR WATSON: Would you write me a letter 
to that extent? 
MR. CAVANAUGH: Sure, yes we will. 
SENATOR WATSON: Thank you very much. 
MR. YOKOHAMA: Thank you for the opportunity. 
Also, I'm not sure if it would be useful, but we do have 
the minutes of the last meeting. 
SENATOR WATSON: Oh, we'd like to have that. 
MR. YOKOHAMA: Thank you very much, appreciate 
it very much. 
(Witnesses were excused.) 
SENATOR WATSON: I'd like to call up now the 


























Angeles, Gil Gerald. 
STATEMENT BY GIL GERALD 
MR. GERALD: Good afternoon. 
SENATOR WATSON: Good afternoon. 
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MR. GERALD: Senator Watson and Honorable 
Members of the Senate Health and Human Services 
committee, my name is Gilberte Gerald,and I am currently 
the Executive Director of the Minority AIDS Project. 
I have been involved for more than six years in 
the response to AIDS and what is usually termed, in public 
health jargon, the minority community. Minorities, in 
fact, make up or are emerging as the majority in many 
urban centers. HIV transmission through needle sharing is 
a significant threat to our communities because drug use 
and abuse has surpassed epidemic proportions. 
In California, as has been stated, there may 
till be an rtunity to prevent the higher incidence of 
HIV disease among IV drug users that has occurred in the 
northeastern cities of the United States. I thank you 
for this o rtunity to present testimony offering support 
for needle exchange programs. 
Needle exchange should be instituted as part of 
a com ehensive set of programs that are desperately 
needed to combat both the HIV and drug use epidemics. The 
views I offer on the question of needle exchange come 
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mainly from work on a report conducted under my direction 
2 while I was the Director of Minority Affairs for the 
3 National AIDS Network in washington, D.C. The results of 
4 this report were published in the June and July 1989 issue 
5 of NAS Newsletter, multi-cultural notes on AIDS education 
6 and service. 
7 The report looked at a number of needle exchange 
8 programs underway around the country and the public debate 
9 surrounding them. A recent check with the sources of this 
1o report reveal no significant new information. I'm 
11 submitting copies of this article as part of my testimony 
12 which I've provided to you. 
13 Before speaking on the issues of the efficacy of 
14 needle exchange programs, I would like to offer the 
15 following commentary on one basic political issue posed by 
16 needle exchange proposals. A major problem with the 
17 public debate surrounding needle exchange programs is that 
18 these proposals are often presented or perceived as 
19 substitutes for a comprehensive set of programs that are 
20 desperately needed for the intravenous drug using 
21 population. This is a false construct which sets the 
22 stage for a lot of drama. If, in fact, there is no will 
23 by government to respond to the pent up demand, to apply 
24 the necessary resources to help the individual intravenous 



























community, particularly the African-American community 
will be hard pressed to understand why there is now a will 
to fund a program that at this time can only partially 
answer the question of whether it will stop the spread of 
HIV. 
In this sense, the needle exchange programs are 
pitted against a whole set of unmet needs and are seen as 
a bandaid solution to a much larger problem, the drug use 
epidemic and it's root causes. 
Needle exchange programs need to be viewed in 
the context of the need for a comprehensive set of 
programs in which they are but one of a whole arsenal of 
strategies that need to be employed to deal with the HIV 
and drug use epidemic. This comprehensive set of programs 
should include ograms including treatment on demand with 
a full range of options beyond methadone, as well as 
ograms oviding referral and full access to medical, 
mental health, housing, job training, job placement, child 
care and legal services. 
In experience it is this set of 
comprehensive set of programs that strikes a responsive 
chord in the African-American community. Having said that. 
I wish to offer a word of support for needle exchange as 
one strategy among many, all of which must be brought to 
bear on the problem of stopping the spread of HIV among 
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intravenous drug users. Behavior change is very difficult 
2 to bring about, but small changes in risk behavior mean 
3 a lot when it comes to HIV transmission,and time is of 






















needles may not seem as great an accomplishment as getting 
him or her off to kick the habit altogether. However, 
with this one small step towards responsibility for 
oneself and others, this one step is a giant leap for an 
addict and a giant leap towards stopping the spread of HIV 
to their sexual partners and their unborn children. 
Information from needle exchange programs in 
this country, including one in Tacoma, again, checking my 
resources for the report written earlier this year, 
indicate the following: (1) Drug use, as has been stated 
before, has not increased as a result of needle exchange 
programs. In Tacoma, of an estimated 300 to 350 regular 
users of the program, the median number of years the 
participants have been using drugs intravenously is 14 
years. Further, there is no difference in the level of 
drug use pre-and post-participation in this program. 
(2) Needle exchange sites have proven to be 
ideal sites for recruiting or referring individuals into 
treatment. Again, in Tacoma over 200 individuals were 
recruited into treatment, half of which remained in 


























underscored. Needle exchange programs can be points of 
entry and access to a whole set of programs designed to 
support the IV drug user in his or her journey away from 
drug dependency. In this sense it is another kind of 
outreach program, as Doctor Evans has stated. 
(3) From the standpoint of behavior change with 
respect to the sharing of needles, the Tacoma program 
reports that half of the individuals had already 
eliminated needle sharing before entering the needle 
exchange program, as a result of other prevention efforts. 
The needle exchange program was able to get another third 
to eliminate needle sharing as a behavior,and the use of 
bleach increased 50 percent. 
Clearly, needle exchange programs can fill gaps 
left by other approaches to reach intravenous drug-using 
populations and achieve behavior change. It is yet 
another demonstration that we need an eclectic approach to 
HIV evention utilizing many strategies, not one. 
Needle exchange is not a panacea. It is part of 
a set of strategies that must be employed, including 
treatment on demand, bleach and condom distribution and 
information about the proper cleaning of drug 
paraphernalia. 
All needle exchange programs should be funded 
and supported in a way that provides for good evaluation 
of the effectiveness of the program. Because most 
2 programs underway are new, it will take years and large 
3 samples of individuals to determine how effective they 
4 were in actually stopping the spread of HIV. This is a 
5 question for which there is no definite current answer. 
6 What is known is that certain needle sharing behaviors 
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7 lead to HIV transmission and that needle exchange programs 
8 are documenting reductions in this behavior as a direct 
9 result of individual participation in needle exchange 
10 programs. 
11 To wait indefinitely for absolute proof, and 
12 some members of the community demand that, that needle 
13 exchange programs, the spread of HIV before instituting a 
14 sanction program in California, a leading state in numbers 
15 of diagnosed AIDS cases, is unreasonable in light of the 
16 evidence that needle exchange programs do lead to 
17 reduction in the behaviors that provide for the 
18 transmission of HIV. What is reasonable is to require and 
19 fund evaluation over a long run to ultimately answer the 
20 question of efficacy. 
21 In conclusion, I would urge members of the 
22 Committee on Health and Human Services to further examine 
23 the objective data that is available on needle exchange. 
24 The HIV crisis is closing in on its first decade. As the 

















to the c~isis of AIDS in south Central Los Angeles, I am 
well aware how unpopular needle exchange is in the 
community here or elsewhere. However, much that the 
Minority AIDS Project and others have had to do to save 
lives and take care of one of those in need, could not 
wait for popular public outcry. 
SENATOR WATSON: Okay, then how do we address 
the concerns that were just mentioned before, such as, 
those of Commissioner Gray,and the religious community? 
MR GERALD: I think that-- I've read the 
objections by Commissioner Gray and I would support the 
statements that have been made earlier about perhaps 
legislation that made it legal for an agency to take on 
is responsibility in the state of California. Beyond 
that we have to have quite a bit of community education 
16 around this issue and basically, presenting the facts. I 
17 also think t t we need to position this issue in the 
18 context of a comprehensive program that the community is 







intervention around HIV. They really are concerned about 
the under ying issue of IV drug use. And yes, a speaker 
did speak about separating those issues. I think that's 
a to ask n the community. I think people do want to 
see more than just they would like to hear more about 
how this program does get people into treatment, how this 
program does,is a point of access to people who are not 
2 currently accessed through existing programs. 
3 SENATOR WATSON: I would like to share with 
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4 you the letter from Commissioner Gray,and you might want 
5 to look at it in terms of how you would respond. Would 
6 you do that for us? 
7 MR. GERALD: Yes, I would. 
8 SENATOR WATSON: I'll have Mr. Stewart share 
9 it with you. Here it is. 
10 MR. GERALD: I do have a copy of it. 
11 SENATOR WATSON: Oh, you have a copy of it? 
12 MR. GERALD: Yes, I have seen it. 
13 SENATOR WATSON: I'd be interested in seeing 
14 your recommendations and your response to what she has 
15 sent us, if you would. 
16 MR. GERALD: Certainly. 
17 SENATOR WATSON: Okay, thank you so very much, 
18 and we appreciate what you've done and prepared for us. 
19 MR. GERALD: Thank you, Senator Watson. 
20 (Witness was excused.) 
21 SENATOR WATSON: I'd like now to just skip 
22 and call up Sherry Conroy of the Department of Alcohol and 
23 Drug Programs because there are some questions that I'd 
24 like her to respond to. 


























down in front, we'll take you right afterwards and 
continue on with the agenda. 
STATEMENT BY SHERRY CONROY 
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MS. CONROY: Since you're running so far behind 
and you were kind enough to accommodate my flight 
schedule, I'll forego reading my testimony as submitted. 
SENATOR WATSON: Thank you. Just submit it, 
and we '11 all get a chance to read it. 
MS. CONROY: Okay. 
SENATOR WATSON: Can I have the sergeant come 
down and get a copy of her statement, please? 
MS. CONROY: Just to briefly summarize, the 
first part of my testimony was to talk about the various 
activities the department's been engaged in either 
directly or through our 58 counties to prevent the spread 
of HIV and AIDS. We're very proud of those activities,so 
1 would hope that you'll take a few minutes sometime later 
o get acquainted with our activities. 
Those activities involve training, education and 
prevention HIV testing with pre-and post-counseling: and 
treatment on demand. We see those as the three primary 
strategies for my agency to be involved in. The bottom 
line of the testimony is, however, although the 
preliminary data from needle exchange projects both 











prove definitively that they do not encourage the use of 
drugs,and for that reason,our department does not support 
needle exchange programs. 
SENATOR WATSON: Cut and dried, that's the 
end of it? 
MS. CONROY: That's it. 
SENATOR WATSON: I know that it's difficult 
when the word comes down from the top to take a position, 
but I'm not clear. You might want to reiterate for me why 
you are against, at this point, the needle exchange 
















MS. CONROY: Many of the needle exchange 
programs, first of all, are not stringently, 
scientifically designed to show that they do not encourage 
drug use. 
SENATOR WATSON: Tell me this, on that point 
right there, what is the Department doing to advance and 
discourage the use of drugs? Advance your programs and 
discourage the use of drugs, what have you done 
successfully? 
MS. CONROY: Well, I think we have a number of 
things --
SENATOR WATSON: And lowering the rate of 



























I think probably our best efforts 
are our prevention information, both efforts in our 
treatment programs and outreach efforts where we provide 
information on how not to attract the HIV virus or spread 
the virus. I think our HIV testing plus counseling 
program, in conjunction with the Office of AIDS within the 
Department of Health Services,is extremely effective in 
getting IV DU's to go into 
SENATOR WATSON: What evidence do you have 
that it is extremely effective? 
MS. CONROY: We're in the early phases of it, 
senator Watson, so I am remiss in saying that it is 
extremely effective. I believe that it will be extremely 
effective. 
SENATOR WATSON: Okay, you pass this word on 
t I want to see the evidence that what you're doing is 
paying off in terms of curtailing the spread of 
AIDS in terms of reducing the number of those who use 
IV's. I'm not so sure I agree with you and I'm giving you 
this word to pass on up and I really think that the 
D rector might be more in agreement with this report than 
u're able to say right now. But I really think we have 
an epidemic on our hands,and I just haven't seen the 
evidence coming out of the Department that what is being 


























what level of emergency we are at at the current time. 
So just pass that word on that we're going to be 
asking for documented evidence that the efforts through 
the Department are really paying off. 
MS. CONROY: I really hear you, Senator Watson. 
I'd like to say a couple of things. One is a little bit 
off track, but I think if you looked at the National 
Household Survey on drug use we are seeing a drop in more 
recreational drug use. We still have hard core drug 
users, people that are addicts 
SENATOR WATSON: For California, for the city 
of Los Angeles, San Francisco, Richmond, Oakland? 
MS. CONROY: For California as a whole. 
SENATOR WATSON: I would be very impressed if 
I could see that data on Los Angeles, San Diego, Richmond, 
you know, the areas where the drug use is high. When we 
see the national surveys they look at Podunk, Iowa, you 
know, sure you had five people on drugs,and now you have 
two. That doesn't really compare well with what we have 
here in California,and let's try to focus in on 
California, particularly the urban centers and see what 
we're doing in that regard. 
MS. CONROY: Okay. The other thing that I 
wanted to say is the prior testimony that I skipped over 

























t~eatment and p~evention fo~ HIV testing, pre and post-
counseling --
SENATOH WATSON: And I do log the work we've 
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done to get that out to the Departments. It was a big 
fight and there were people who challenged us all the way, 
but the majority prevailed,and you now have the funds to 
at least get started. Now, I want you to track it very 
carefully because we will like to see the data and to see 
if the money we're investing is really paying off or have 
we invested enough. 
These are messages to be taken back. Thank you 
so very much and we appreciate you waiting this long. 
MS. CONROY: Thank you. 
(Witness was excused.) 
SENATOH WATSON: Doctor Horowitz, it is good 
to see you. 
DOCTOR HOROWITZ: It's good to be seen. 
SENATOR WATSON: Pull that mike right up. 
STATEMENT BY DOCTOR THOMAS HOROWITZ, M.D. 
DOCTOR HOROWITZ: It's good because of the time 
that 90 percent of what I wanted to say was said and I see 
no reason to go over it. 
The two things we need to stress is that there 
are numerous myths out there. There is the myth that 
anything to help a drug user encourages their use,and this 
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has never been proven. There is the myth that drug users 
2 are incorrigible,and tests only at our Commission has 
3 shown that we can have good inroads into the heroin-using 
4 community. It's more difficult to hit cocaine use because 
5 of the nature of the drugs; and lastly, that anything we 
6 do will interfere with law enforcement. Obviously, we're 
7 getting into delicate areas here. Obviously, any plan has 
8 to be done in such a way that is rational, both from a 
9 public health viewpoint and a law enforcement viewpoint, 
1o but we've negotiated with law enforcement in many other 
11 areas,and there's no reason why we can't be on the same 
12 side, much as our outreach workers are seen as anti-drug 
13 people on the streets. 
14 It is a very, very strong anti-drug message when 
15 you have community people, who are accepted in the 
16 community, saying we're not going to give you any 
17 morality; we're not going to give you any law; all we're 
18 going to tell you is that this stuff is bad; it can kill 
19 you. And, if you're going to use, protect yourself and 
20 more important, protect anyone you love. That's the 
21 message we have to get out onto the streets. 
22 We're getting it there with our outreach workers, 
23 but we have 30 of them and that's, you know, not a 
24 significant number. We need to increase that; therefore, 



























needles are a tool in this war, but it still is not going 
to build a house. It has to be put in the framework. 
There has to be treatment on demand. There has to be 
health educators who are accepted in the community. We 
find the outreach workers are the most useful. There then 
have to be social service agencies that can work with the 
outreach workers because these are street people, 
frequently, people who aren't going to present to the 
facilities, who don't have easy access to telephones to 
make the appointments and don't have easy transportation 
to the facilities. 
Additionally, there are the tools of education, 
teaching them how to clean syringes if they continue to 
use. When they're ready to go into treatment, how to get 
into treatment, and of course, it's pathetic but in L.A.; 
the best we can do is a three-week wait,and for a person 
with drug se disease,they are impulsive,and you've got to 
work with that impulse. When they have the impulse to use, 
they'll use. When they have the impulse to go into 
treatment, they'll go into treatment. 
L.A. is a divided community and as such, as we 
look at this issue,we find there are different solutions 
in different communities,and you have to look at each 
community separately. It takes a different type of 
outreach worker with a different message with different 
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equipment, and the sad commentary is our hands are tied. 
2 In Los Angeles we have not come to a conclusion 
3 that a needle exchange program would be a major tool. It 
4 definitely wouldn't hurt,but I'm not sure it would be a 
5 major advantage,and I'm still learning about it,and I'm 
6 still studying it in each of the communities. What is sad 
7 is that in communities which are convinced, such as San 
8 Francisco, to have their hands tied is pathetic. That is 
9 really what I feel today is all about. If we're going to 
10 have a state policy, it has to be a state policy that 
gives a path of least resistance to treatment programs and 
12 to all the tools they need, and if we're going to have 
13 just a local issue, the state policy has to allow it to be 
14 a local issue without the hands being tied. 
15 With the support of the Pharmacy Board, with the 
16 support of the medical community, I believe that a 
17 credible plan can be developed which will have limitations 
18 so that it would not become a tool for the drug user but 
19 stay what it needs to be, a tool for drug treatment. A 
20 person who uses drugs is going to afford those drugs 
21 through criminal activity frequently or through 
22 prostitution or through other acts that spread the virus, 
23 and that is what it's important. If we can clean the 
24 streets of the AIDS virus,it's safer for all of us, 

























including our emergency room personnel. 
We have to look at this issue rationally rather 
than emotionally. unfortunately, it's emotionally 
charged. I cannot tell you what the Commission's stance 
will be as time goes on. As it is now, we feel we get 
more "bang per buck" from our outreach workers,but as I 
said,there are communi ties where this may be a tool that 
can help them. I don't know that,but it's sad if we make 
this decision,our hands would still be tied. 
SENATOR WATSON: Doctor Horowitz, I wonder if 
you'll stay seated,and I'd like to hear from the next two 
presenters, and maybe we can have an exchange as to how 
we'd work with them. 
The next two are Doctor Bruce Mitchell, 
Commanding Officer of the Narcotics Division, Los Angeles 
Police Department, and Commander Larry L. Anderson, 
irman of the Los Angeles County Sheriff's Task Force. 
Is Commander Anderson here? 
MR. ANDERSON: Yes. 
SENATOR WATSON: Would you come and join us 
please,and we'll take you as a panel here. 
All right, Captain Mitchell. 
STATEMENT BY CAPTAIN BRUCE MITCHELL 
MR. MITCHELL: Thank you very much for inviting 























Since I was invited here to speak I'm going to 
speak as a law enforcement professional, and address the IV 
drug abuse problem from that perspective. That includes 
what I believe the effect on the crime rate is, the laws, 
the victims and property loss. 
The bottom line is the Los Angeles Police 
Department does not support any form of a needle exchange 
program,and I'll explain a little bit why we have that 
position. 
As you know, it's currently against the law. 
There are a number of Health and Safety Code Sections that 
prohibit the possession of hypodermic needles and many 
other "paraphernalia", but to support any kind of a 
program like this is, in effect, giving tacit approval to 
drug addicts and users and indirectly supporting the 
sellers of those illicit drugs. As law enforcement 
officersrwe cannot condone breaking the law by supporting 
drug abuse in order to solve a health problem. 
The City's crime rate under this program, as it 
is right now, would just continue to remain unacceptably 




the property loss due to all types of theft crimes would 
continue. IV drug usage has a direct correlation to the 



























receiving stolen property, prostitution and shop lifting. 
Because of the addictive nature of the heroin addict, 
who is your typical IV drug user, they commit many more 
crimes then the typical non-drug user. The typical heroin 
user has a habit of approximately $100 to $150 a day to 
support his habit, and to support that habit, he has to 
steal anywhere from $300 to $400 worth of property that 
belongs to the citizens of the country, the city, or our 
community to support that habit. They're stealing from 
the good citizens of this city to support their illegal 
drug habit. 
I think the link between drug use and crime has 
been firmly established throughout the years,and one 
cannot be at the exclusion of the other. Localities 
expressing high rates of illegal drug use also experience 
high rates of criminal activity. 
Some of the estimates that I've read on the 
number of IV drug users in the City of Los Angeles, vary 
from 60,000 to 100,000. I heard some testimony today 
about studies,and they indicate that there's no evidence 
that a needle exchange program would cause the crime rates 
to go up or IV drug users to increase in the number. How 
can they be so certain when the estimates are so wide, 
from 60,000 up to 100,000. 
SENATOR WATSON: Let me ask you this. If 
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they already have a needle, and that's what I understand 
2 the exchange program is, they already have a needle and 
3 they're just replacing that needle, one for one. 
4 MR. MITCHELL: And the way we see that, that's 
5 not going to stop your IV drug user from exchanging that 
6 needle with their other users. The way they typically use 
7 it-they'll purchase their heroin, that's usually right 
8 downtown here in Los Angeles, and they'll take five and 
9 six and seven people together they'll go over in some 
10 corner where they are secreted from the public,and they 
11 will heat up that heroin;and they will inject it right 
12 there,and all six of those people will exchange that same 
13 needle. So whether they have that one needle that is left 
14 over from the previous shooting, or they have that needle 
15 that they're using for the first time, they're still going 
16 to share that needle. 
17 I think it's unrealistic to expect each and 
18 every IV drug user to have a single needle that they use 
19 one time and only for themselves. 
20 SENATOR WATSON: No, what I understand is 
21 that you don't get a new one unless you have one to turn 
22 in. So, if twenty people use it it's still the same 
23 needle, you know, they only get one needle. 
24 
25 
MR. MITCHELL: That's correct. 
SENATOR WATSON: You're not increasing the 
number of needles in circulation. You're increasing the 
number of needles that are clean. 
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2 
3 MR. MITCHELL: Or what are believed to be clean 
4 and they would only be clean at the time the first person 
5 uses the needle. 
6 
7 
SENATOR WATSON: Correct. 
MR. MITCHELL: Apparently there would not be 
8 more needles on the streets, from the program. 
9 SENATOR WATSON: Right, that's what 1 
10 understand from the program. 
11 MR. MITCHELL: I don't contradict or argue that 
12 point. 
13 With a needle exchange program,what is of 
14 concern to me as a law enforcement professional with 25 
15 years in law enforcement is that our heroin use today is 
16 increasing. It's gradually increasing and has been 





SENATOR WATSON: Now, let me ask you. Do you 
think that's the result of a needle exchange program in 
San Francisco? 
MR. MITCHELL: No. But it's a part of the 
22 problem in that heroin use is increasing,and at the same 
23 tirne,our IV cocaine use is increasing. They differ a 
24 little in that the typical heroin user will shoot up and 
25 then they'll nod off for sometimes as short as an hour, 
91 
sometimes as long as six and eight hours, something like 
2 that. It depends on that person's tolerance. Then 
3 they'll shoot up again, and they'll shoot up again. But 
4 what's of concern to me is the cocaine user now who's also 
5 using an IV, and by doing that, they have to shoot up much 
6 more frequently. Sometimes they'll have to shoot up as 
7 frequent as every 30 minutes to sustain that high. A 
8 needle exchange program is not going to help this type of 
9 a law enforcement problem. 
10 SENATOR WATSON: But when you look at it 
11 it's not only a law enforcement problem, it's a public 
12 health problem too. That's what we're trying to solve. I 
13 understand that awesome problem law enforcement has to do. 
14 I understand also the epidemic nature of the problem in 
15 terms of AIDS and the spread of AIDS. 
16 The reason why the Health committee and not the 
17 Judiciary Committee is holding this hearing is because we 
18 are looking at it from a health standpoint. 
19 MR. MITCHELL: I understand that. 




SENATOR WATSON: Go ahead. 
MR. MITCHELL: The department agrees that the 
24 AIDS epidemic is a major health problem affecting the 
25 entire U.S.,and we feel that we have to have a strategy 
1 that has a permanent solution;and the way to do that is 
2 through public education and some of the treatment 
3 programs that a number of your experts have already 
4 mentioned. The Los Angeles Police Department supports 
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5 those programs. We're not opposed to any of the programs. 
6 We're simply opposed to the needle exchange portion of any 
7 of these outreach programs. 
8 We have one program that we use in law 
9 enforcement. In the Los Angeles Police Department,we call 
10 it the DARE program. 
11 SENATOR WATSON: I'm very much aware of that. 
12 MR. MITCHELL: My colleague also has a program 
13 that is very much effective,and it is called the SANE 
14 program. They both are designed to reach elementary 
15 school children. What we tell those children is how to 
16 say "no". That's the message. we truly tell them how to 
17 "no",and studies that have been conducted have shown 
18 that programs like that do work. Children who have been 
19 exposed to the DARE program are less apt to use narcotics 
20 than those who have not been exposed to it. 
21 How do we tell a student at that age to say "no" 
22 and absolutely never use narcotics, but by the way, if you 
23 decide to use it,use a clean needle. I think as a 
24 professional we're losing all credibility with our 
25 children. We have to tell them don't use it. We can't 
1 say don't use it, except if you do and add the needle 
2 program. It doesn't work that way. If we want to 
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3 convince our children that narcotics use is bad,we have to 
4 tell them it's bad,and there are no exceptions. Then we 
5 have to have some treatment programs. 
6 How law enforcement can help there is by when a 
7 person is identified as an IV drug user, we can see that 
8 they're directed from the criminal justice system,and they 
9 get that appropriate, permanent education, some long-term 
10 programs. And that's how we can help is in the 
11 identifying abusers. 
12 SENATOR WATSON: I want to commend law 
13 enforcement for its DARE program. I have a lot of respect 
14 for that program, and it does pay off with young people. 
15 we are concerned about those adults now that can father or 
16 bear children, and what is happening to them, and how we 
17 address this challenge. It's bigger than all of us. Even 
18 with the use of crack cocaine, I'm listening and tuning in 
19 to what we did during the suffrage period and what we did 
20 with alcohol. I don't know how to win this war and I 
21 think in partnership,we can at least debate it, and 
22 that's what this is all about. 
23 So, I want to thank you and Doctor Horowitz. 
24 When we finish with the next witness I would like you to 
25 comment. 
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1 Let me ask now for Commander Anderson to 
2 continue. 
3 STATEMENT BY COMMANDER LARRY ANDERSON 
4 MR. ANDERSON: Thank you, Senator. I'm Commander 
5 Larry Anderson from the Los Angeles County Sheriff's 
6 Department and for my statement I want to take about five 
7 minutes, Senator, if you'll bear me out. 
8 The Los Angeles County Sheriff's Department 
9 opposes any amendment to existing law that would permit 
10 health authorities to have the discretion of providing a 
11 needle exchange or distribution to intravenous drug 
12 abusers. Of course, as you know, the current law in 
13 California does prohibit the distribution or possession of 
14 drug paraphernalia. 
15 The underlying issue that we're dealing with 
16 today is really identifying and implementing programs that 
17 might be effective in reducing the spread of HIV among 
18 drug abusers. Needle exchange is only one alternative 
19 that is being experimented with in several communities in 
20 the United States. The first government-sponsored needle 
21 exchange program was initiated in New York City in 1988, 
22 and that report on results to date is not due until the 
23 end of this year. It's apparent, however, that the number 
24 of IV drug abusers in the program represent only a 
25 minuscule percentage of the number of IV drug users in New 
1 York and we're not aware of any data that would indicate 
2 that needle exchange programs have been successful in 
3 reducing seropositive rates among addicts. To engage in 
4 further experimentation without valid information from 
5 existing programs, we don't feel would be prudent. 
6 Needle exchange programs and needle exchange 
7 does not prevent the sharing of needles, as Captain 
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8 Mitchell has mentioned previously. It's the sharing that 
9 spreads the virus. Sharing a new needle is just as 
10 dangerous a practice as sharing an old one. It's the 
11 sharing behavior that must be modified. Providing a new 
12 syringe is a method to allow a drug abuser to continue to 
13 use unlawful substances. 
14 Let's consider the message the government would 
15 be sending out, especially to our young people after our 
16 pronouncement of a national strategy to wage an all-out 
17 war on drugs. Our people and our young people in society 
18 already receive too many mixed messages. We can't afford 
19 to compromise on this issue,and the message against drug 
20 abuse must be clear. It must be recognized that our drug 
21 problem is user-generated. 
22 Lawful alternatives to expanding the 
23 availability of drug treatment programs must be thoroughly 
24 considered. The California Department of Health Services 
25 has reported that 92,000 to 95,000 persons are being 
ted into drug treatment programs yearly, with about 
2 35,000 of those persons in publicly funded Los Angeles 
3 Coun Programs. Additionally, in a survey conducted 
4 statewi the state health officials, in a 
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5 r esentative sample 96 percent of the intravenous drug 
6 users recognized IV drug use as very related to getting 
7 AIDS. Nine seven percent perceived sharing dirty 
8 les as being very related to getting AIDS. However, 
9 practice of their high-risk behavior didn't seem to 
10 t awareness. Again, supplying a clean needle 
11 the drug abuser is sharing it with another is not 
12 goi to solve the problem. 
13 The drug problem is one of demand. The user is 
14 the s c oblem in creating a market for illicit drugs 
5 and every action must be considered in preventing drug 
25 t l e 
tifying those persons who need the 
Ex i sti law prohibiting the distribution and 
f drug paraphernalia provides us a means to 
d ug sers so that judicial action can be 
ps rna atory drug treatment should be 
or those identified abusers who have not 
oluntary treatment and assistance. 
WATSON: If I might just interru~t 
t 1 S the kind of thing that I propose but they 
t it's too costly. I wanted mandatory 
1 treatment,but the state government or county government 
2 would have to then fund that treatment and supply that 
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3 treatment. But I think that's one of the solutions to it 
4 also. And you heard the other witnesses say it's just not 
5 accessible. 
6 MR. ANDERSON: That's the problem. Effective 
7 drug treatment programs need to be readily available to 
8 anyone requesting help and at little or no expense to that 
9 individual. 
10 A significant legal question must also be 
11 addressed concerning any legal exchange program. Consider 
12 this question. If a government entity furnishes a device 
13 with the knowledge that it would be used to inject an 
14 unlawful and dangerous substance into the human body, that 
15 government entity may be liable for the resulting 
16 consequences including the death of an individual that 
17 could reasonably be expected from such activity. 
18 The solution to the drug abuse and health 
19 problems is not in furnishing needles so that abusers can 
20 continue their lifestyles. If we as concerned citizens 
21 are truly dedicated to winning the war against drugs and 
22 stemming the spread of disease, we will strengthen 
23 prevention programs along with drug treatment availability 
24 and without compromising our existing laws. 


















points t we'll have to really consider. What we're 
going to do is pull together the laws in the other states 
where they do do legal exchange to see what the legal 
implications are when there are bad results. I think you 
hit on some legal questions that we have to look at. 
MR. ANDERSON: May I address that just for a 
moment, Senator? 
SENATOR WATSON: Sure. 
MR. ANDERSON: Portland, Oregon has had a needle 
exchange program,and in the state of Oregon,there is no 
law against the possession of controlled, of needles, or 
it was very easy for them to implement a program. They 
had no law that prevented that position. 
In Tacoma, washington, I understand their 
program 
SENATOR WATSON: How does that exclude them 
7 from li ili 
18 MR. ANDERSON: I don't know that it does. I 
don't know that it excludes anyone from liability. 
20 WATSON: Well we'll check with Oregon 
21 and see t their experience has been. 
MR. ANDERSON: In Tacoma, for example, I know as 
23 was mentioned earlier by other speakers, I understand that 
24 that pr ram was city-funded by the city of Tacoma for 
25 about $44,000; and the State's Attorney General has 
recently ruled that the decision by the State Health 
2 Officer was improper, and it was unlawful; and he has 
3 ordered that that program be shut down as far as expense 
99 
4 to the City of Tacoma. That issue is in the courts in the 
5 State of washington right now. 
6 Boulder, Colorado was also mentioned a little 
7 earlier. That activity as far as the distribution of 
8 needles is against the state law in Colorado,and the 
9 District Attorney in Boulder, Colorado, I understand, has 
10 given his permission for the health officials to engage in 
11 the program and indicated he would not prosecute those 
12 individuals for distributing needles to the IV drug 
13 abusers. 
14 New York is another matter. There is all manner 
15 of law,and all of the programs that were mentioned in 
16 foreign countries, again, there's all manner of law, all 
17 manner of culture, of social practice, grown up through 
18 decades, and I think that it would be very imprudent for 
19 us to base our programs against the practices of some of 
20 those countries where their laws and social practices are 
21 quite different from ours. 
22 SENATOR WATSON: I don't think that's our 
23 intent at all. Our intent is to find out what the other 
24 states are doing and their experience. 















there, I'd like Doctor Horowitz, since you mentioned law 
enforcement in your presentation, a way of working with 
law enforcement to work out some of the problems, I 
thought you might like to comment on what you've heard. 
think they've stated their positions rather well. 
DOCTOR HOROWITZ: Of course, as I said, I'm not 
a proponent of needle exchange. I am a proponent of 
public health authorities having the ability to do what 
they deem is necessary. In looking at our Committee, we 
have not seen this as a step that is appropriate for L.A. 
county. The reason being, I go out on the streets; I've 
seen the shooting galleries off skid row, and I'm not 
convinced that the needle would be used by one person as 
I 
14 ir prized possession. Some would, but some wouldn't; 
15 and the "bang for buck" I'm not sure is there. 
I'm still 
16 a oponent that if we teach them what treatment's 
avai able, at social services are available, other ways 








safe sex there's safer sex. There is no safe drug use, 
there's safer drug use. And, understanding it's a cost 
benefit and they 1 re playing Russian roulette, and the only 
difference is do they want to do it with a revolver until 
they're re to get into treatment or do they want to do 
it with an uzi? 
The fact is, if you use drugs long enough and 
1 are involved in the activities it takes to afford the 
2 drugs, people are going to get AIDS. All we can do is 
3 educate them and hope they learn before it's too late. 
4 And as I said, my feeling is the outreach worker is the 
5 most important tool. Therefore, we're looking at two 
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6 issues and law enforcement, yes, something like the DARE 
7 program. There's not enough money to do it right. We need 
8 more. That's where we can influence kids. From the South 
9 pacific, "You've got to be taught before it IS too late, 
10 before your six, or seven or eight. " We have to get to 
11 them young, but then they go home and find parents who are 
12 using. We have 3,000 to 5,000 adolescents living on the 
13 streets around Hollywood who are into survival sex, into 
14 drug use. The DARE program won't work for them. We've 
15 got to find ways to get to them. We've got to find 
16 innovative ways of keeping them from getting AIDS. We 
17 have to find better ways to educate the prostitutes and 
18 the jobs. 
19 SENATOR WATSON: Any suggestions or 
20 recommendations that any of the panel here might have? 
21 DOCTOR HOROWITZ: As I said, I think the 
22 important thing is to have a dialogue and to start looking 
23 for answers that don't cripple either of us. 
24 SENATOR WATSON: That's what we have done 










to take a look at it and discuss in a public forum. 
I do thank all three of you and if you'd like to 
make a closing remark --
MR. MITCHELL: Senator, if I may, just another 
remark. I mentioned during my presentation that 
information that we had from the state of California 
indicated that now, at this time, 92,000 to 95,000 people, 
IV drug abusers, are being attracted into drug treatment 
9 programs in the state of California. Something is 
10 attracting them into treatment. However, I think what has 
11 to be looked at is that's a small number compared to what 
12 we probably have in the state of California. It been 










one, but the point is, I think,that we have to look 
ly at what kind of successes we're already having. 
of programs do we already have? How can we 
those programs that currently exist and give 
a hand who are trying to get the job done 
WATSON: I think people will go and 
seek help 1f they know about it and if they have hit that 
i where they reach out. What we need is the support, 
the comm tment,and the advocacy. Law enforcement could be 
very, very 1 ul in asking that we have more money go in 
and more expertise go into these programs so we can 
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generalize them to the entire state. There might be a 
2 good program in the Bay Area, a good program down in San 
3 Diego, but we have the problem statewide, and we do need to 
4 have the correct appropriations to see that these programs 
5 are more successful. 
6 So, you may close. 
7 MR. MITCHELL: Excuse me, Senator Watson. With 
8 the President's new anti-drug program that is just 
9 published today, as I understand, hopefully there will be 
10 a lot more money for not only combat drug abuse, but for 
11 treatment programs also. I'm sure there is going to be 
12 some grant money available,and perhaps we could have some 
13 type of a program that could combine law enforcement and 
14 then track those people all the way through the treatment, 
15 and maybe that could be a pilot program. 
16 SENATOR WATSON: Sure. Could you say that 
loud and long, please? 
MR. MITCHELL: You bet I will. 







22 SENATOR WATSON: 
(Witnesses were excused.) 
Finally, John Drown, the 
23 Director of a local· Aids agency. Mr. Brown? 
24 Mr. Brown will be our last speaker unless there 



















STATEMENT BY JOHN BROWN 
MR. BROWN: Thank you, Senator Watson, for 
me to the agenda. 
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invo 
As the Executive Director of an agency that is 
in street outreach here in Los Angeles County and 
as part of a coalition of both county and state-contracted 
outreach programs here in Los Angeles County, one 
additional perspective I have as someone who has been 
involved in AIDS education and AIDS prevention since 
virtually inning of the epidemic here in Los Angeles 
Coun , we really have adopted,and I have adopted,a 
agmatic attitude toward these things. Of course, we 
support a needle distribution exchange type of program. I 
think what we see as a problem, or what our frustration is 
here n Los Angeles especially, in dealing with a very 
conservative Board of Supervisors that has authority over 
cy, is that little things become very important, 
inc ng te inology and the way things are being worded. 
think ery good example of this is in the 
zat ons that come up when you talk about pro-
on as o sed to pro-choice. Now here today you 
testimony at all that has talked 
about needle distribution and its values 
alone as an intervention. It's all been in conjunction 
w th a c ehensive program in which needle distribution 
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is certainly a part of. But condom distribution and 
2 bleach distribution is also an important part. There is 
3 no studies at all that have looked comparatively at the 
4 value of needle distribution as opposed to the value of 
5 condom and bleach distribution. It has all talked in 
6 terms of the impact that outreach, comprehensive outreach 
7 has had on affecting HIV infection in a given area. 
a Here in Los Angeles, we have, through necessity, 
g have had to use a lot of very creative ways to do 
10 intervention. We're proud of the things that we've done 
11 even though we haven't-- talking about needle 
12 distribution is abstract-- we can't even distribute 
13 condoms and bleach in Los Angeles County. It may be,and 
14 we have experienced in the last round with the Board of 
15 Supervisors, that in fact, the inclusion of needle 
16 distribution and actually the focus of needle distribution 
17 on that outreach package, that comprehensive outreach 
18 package, in many ways led to a major kind of policy 
19 decision that prevented us from even using condoms and 
20 bleach. What our concern is, being out there daily is 
21 that we see very little possibility of anything happening 
22 the near future to really get needle distribution going as 
23 . part of the comprehensive outreach that's happening in 
24 this state. But, at the same time, we're frustrated over 




street because it has been linked to this "package'', 
in the way, you know, early on abortion was linked to 
anning. When the focus becomes, when you're 
about needle exchange, and what you're really 
t ki about is comprehensive outreach, comprehensive 
A outreach, because you're not talking about needle 
7 exchange alone, what you're doing is you're using 
8 terminology that incites a certain reaction. And, if, in 
9 fact, we can keep the perspective that certainly with all 
10 best conditions, needle exchange would be a wonder 




Hor tz said, the most effective thing out there is the 
outreach worker. The person who is out there saying to 
condoms 
e, we care", and anything we can give them, 
it's a needle exchange program or condoms and 
i 's got to be looked at as what it really is. 
DS outreach package, it's an AIDS outreach 
focus being on needle exchange programs as 
to AIDS outreach programs might sound like a petty 
int, but really it is our experience that we lost, 
e talking about a year into this, that we lost 
e of condoms and bleach and the distribution of 
ble over the needle exchange issue. 
I would just like to say in closing, that we 
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appreciate you conducting these hearings and keeping this 
2 issue alive,and the leadership you have taken in regards 
3 to AIDS and substance abuse; and in the future if there 
4 could be more of an emphasis on the establishment of a 
5 definition of comprehensive AIDS outreach and the 
6 implementation of comprehensive AIDS outreach without 
7 necessarily always focusing on the fact that, or calling 
8 this a needle exchange program, even though needle 
9 exchange does need to be part of it. 
10 SENATOR WATSON: I think we certainly get 
1·1 your point,and I think you're absolutely right. When we 
12 start breaking this program up in component parts and 
13 throwing up those red flags, we're in serious trouble with 
14 a moral outrage reaction. We do need to learn how best to 
15 describe what it is we want to do. And a comprehensive 
16 program certainly is what we would like to use as a goal. 
17 As we conclude the hearing today, I just want to 
18 say that I think we are a little more enlightened. We 
19 certainly will take this information back to Sacramento. 
20 We'd like to call on you to assist us in thinking through 
21 what the program ought to be. I am not sure what kind of 
22 legislation will come out of today's hearing. I do know 
23 earlier this morning Senator Seymour's legislation was the 
24 focus of our hearing. This afternoon we talked about 
25 needle exchange,and we did talk about that because that is 
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1 a highly controversial program that is being casually or 
2 illegally operated on the streets, but one of great 
3 interest because it pretends to be,might be one of the 
4 facets of an overall program. 
5 There will be continued debate. I thank you for 
6 s nding the afternoon with us. I thank you for your 
7 testimony,and I will now adjourn this meeting. 
8 (Whereupon, at 4:09p.m., the above-entitled 
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